{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "XNreylskbdl5"
      },
      "source": [
        "# MIMIC NLP HW3\n",
        "\n",
        "## Setup\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "kY0toPrQOT0O",
        "outputId": "6f89ffcc-819a-4f93-9994-79d5c5417055"
      },
      "outputs": [],
      "source": [
        "%pip install -U pip setuptools wheel\n",
        "%pip install spacy==3.7.5\n",
        "%pip install gensim\n",
        "%pip install transformers\n",
        "\n",
        "import spacy\n",
        "from spacy import displacy # Entity Visualizer\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "from sklearn.manifold import TSNE\n",
        "import os\n",
        "\n",
        "!python3 -m spacy download en_core_web_md\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [],
      "source": [
        "MIMIC_3_DIR = '../mimic/mimic-iii-clinical-database-1.4'\n",
        "os.chdir(MIMIC_3_DIR)\n",
        "\n",
        "# Load diagnosis & notes data\n",
        "diagnosis_df = pd.read_csv('DIAGNOSES_ICD.csv').set_index('ROW_ID')\n",
        "notes_df = pd.read_csv('NOTEEVENTS.csv', low_memory=False).set_index('ROW_ID')"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Target Infections"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [],
      "source": [
        "# Create a dataframe with only discharge summaries\n",
        "discharge_summaries_df = notes_df.loc[notes_df['CATEGORY'] == 'Discharge summary', ['SUBJECT_ID', 'HADM_ID', 'TEXT']]\n",
        "\n",
        "# discharge_summaries_df.head()\n",
        "\n",
        "# Common infection codes\n",
        "infection_codes = ['0380', '03810', '0382', '0383', '03842', '03843']\n",
        "# Filter for only infection codes\n",
        "infection_df = diagnosis_df[diagnosis_df['ICD9_CODE'].isin(infection_codes)].copy()\n",
        "\n",
        "infection_types = {   \n",
        "    \"0380\": \"Streptococcal septicemia\",\n",
        "    \"03810\": \"Staphylococcal septicemia, unspecified\",\n",
        "    \"0382\": \"Pneumococcal septicemia [Streptococcus pneumoniae septicemia]\",\n",
        "    \"0383\": \"Septicemia due to anaerobes\",\n",
        "    \"03842\": \"Septicemia due to escherichia coli [E. coli]\",\n",
        "    \"03843\": \"Septicemia due to pseudomonas\",\n",
        "}\n",
        "\n",
        "# Map infection types to infection codes\n",
        "infection_df['INFECTION_TYPE'] = infection_df['ICD9_CODE'].map(infection_types)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 19,
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/plain": [
              "INFECTION_TYPE\n",
              "Septicemia due to escherichia coli [E. coli]                     455\n",
              "Streptococcal septicemia                                         353\n",
              "Septicemia due to pseudomonas                                    116\n",
              "Septicemia due to anaerobes                                      106\n",
              "Pneumococcal septicemia [Streptococcus pneumoniae septicemia]     85\n",
              "Staphylococcal septicemia, unspecified                            43\n",
              "Name: count, dtype: int64"
            ]
          },
          "execution_count": 19,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "# Merge infection data with discharge summaries\n",
        "discharge_summaries_df = pd.merge(discharge_summaries_df, infection_df, on='HADM_ID', how='inner')\n",
        "# Drop duplicates\n",
        "discharge_summaries_df.drop_duplicates(subset='HADM_ID', inplace=True)\n",
        "\n",
        "discharge_summaries_df['INFECTION_TYPE'].value_counts()"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Tokenization & Entity Extraction"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [],
      "source": [
        "# Load specified model (spacy/scispacy)\n",
        "def load_nlp_model(model_name=\"en_core_web_md\"): # Default spacy\n",
        "    try:\n",
        "        return spacy.load(model_name) # Loads specified model.\n",
        "    except OSError:\n",
        "        raise ValueError(f\"Could not load model '{model_name}'. Make sure it is installed.\")\n",
        "\n",
        "# Tokenization function (supports both spaCy & SciSpaCy)\n",
        "def tokenize_text(text, model_name=\"en_core_web_md\"):\n",
        "    nlp = load_nlp_model(model_name) # Loads specified model\n",
        "    doc = nlp(text)\n",
        "    \n",
        "    tokens = [\n",
        "        token.text.lower() # Lowercasing tokens\n",
        "        for token in doc\n",
        "        # Removing stopwords, punctuation, and keeping only words and numbers\n",
        "        if (token.is_alpha or token.is_digit) and not token.is_stop and not token.is_punct\n",
        "    ]\n",
        "    \n",
        "    return \" \".join(tokens)\n",
        "\n",
        "# Named Entity Recognition (NER) function\n",
        "def extract_entities(text, model_name=\"en_core_web_md\"):\n",
        "    nlp = load_nlp_model(model_name)\n",
        "    doc = nlp(text)\n",
        "    # Extracts named entities from text using the specified NLP model\n",
        "    entities = [(ent.text, ent.start_char, ent.end_char, ent.label_) for ent in doc.ents]\n",
        "    # Returns a list of (text, start_char, end_char, label) tuples\n",
        "    return entities\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Spacy Named Entity Recognition (NER)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/var/folders/wd/pkw1ts416gsg2fjyp1rgznqc0000gn/T/ipykernel_96334/2235341693.py:7: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  ecoli_df['SPACY_PROCESSED_TEXT'] = ecoli_df['TEXT'].apply(lambda text: tokenize_text(text, \"en_core_web_md\"))\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "('2194', 15, 19, 'CARDINAL')\n",
            "('7', 22, 23, 'CARDINAL')\n",
            "('2194', 39, 43, 'CARDINAL')\n",
            "('2 2', 44, 47, 'CARDINAL')\n",
            "('290', 121, 124, 'CARDINAL')\n",
            "('age 90', 233, 239, 'DATE')\n",
            "('russian', 242, 249, 'NORP')\n",
            "('ems', 319, 322, 'ORG')\n",
            "('101 bp', 396, 402, 'QUANTITY')\n",
            "('20 98', 406, 411, 'CARDINAL')\n",
            "('4 l ns vanco 1 g', 454, 470, 'QUANTITY')\n",
            "('1 g', 486, 489, 'QUANTITY')\n",
            "('500 mg', 500, 506, 'QUANTITY')\n",
            "('mg ativan 2 mg', 519, 533, 'PRODUCT')\n",
            "('153', 582, 585, 'CARDINAL')\n",
            "('10 day', 596, 602, 'DATE')\n",
            "('7 day', 643, 648, 'DATE')\n",
            "('90', 941, 943, 'CARDINAL')\n",
            "('brady', 1008, 1013, 'PERSON')\n",
            "('4', 1030, 1031, 'CARDINAL')\n",
            "('sec', 1032, 1035, 'ORG')\n",
            "('micu micu', 1097, 1106, 'PERSON')\n",
            "('1', 1150, 1151, 'CARDINAL')\n",
            "('2', 1217, 1218, 'CARDINAL')\n",
            "('17', 1251, 1253, 'CARDINAL')\n",
            "('micu', 1254, 1258, 'GPE')\n",
            "('1', 1273, 1274, 'CARDINAL')\n",
            "('2', 1315, 1316, 'CARDINAL')\n",
            "('3', 1403, 1404, 'CARDINAL')\n",
            "('400 mg po', 1444, 1453, 'MONEY')\n",
            "('daily', 1454, 1459, 'DATE')\n",
            "('7 days', 1464, 1470, 'DATE')\n",
            "('8 23', 1623, 1627, 'CARDINAL')\n",
            "('progression treated cytoxan velban', 1628, 1662, 'ORG')\n",
            "('10 28', 1866, 1871, 'CARDINAL')\n",
            "('4 mg', 1924, 1928, 'QUANTITY')\n",
            "('1 27', 1940, 1944, 'CARDINAL')\n",
            "('50 mg', 1958, 1963, 'MONEY')\n",
            "('velban', 1980, 1986, 'ORG')\n",
            "('ni', 2351, 2353, 'PERSON')\n",
            "('79 bp', 2600, 2605, 'QUANTITY')\n",
            "('nc heent', 2616, 2624, 'PERSON')\n",
            "('sclera anicteric', 2625, 2641, 'PERSON')\n",
            "('2', 2670, 2671, 'CARDINAL')\n",
            "('abd', 2775, 2778, 'PERSON')\n",
            "('1 2 mm', 2973, 2979, 'QUANTITY')\n",
            "('24 94', 3153, 3158, 'DATE')\n",
            "('2', 3314, 3315, 'CARDINAL')\n",
            "('abd', 3433, 3436, 'PERSON')\n",
            "('3 4 mm', 3635, 3641, 'QUANTITY')\n",
            "('micu', 3735, 3739, 'GPE')\n",
            "('102', 3754, 3757, 'CARDINAL')\n",
            "('31 94', 3761, 3766, 'DATE')\n",
            "('heent perrl eomi anicteric tachy mm op', 3841, 3879, 'PERSON')\n",
            "('1 8', 4242, 4245, 'CARDINAL')\n",
            "('1 10', 4373, 4377, 'CARDINAL')\n",
            "('3', 4660, 4661, 'CARDINAL')\n",
            "('2193', 4899, 4903, 'GPE')\n",
            "('12 22', 5129, 5134, 'CARDINAL')\n",
            "('age 90', 5173, 5179, 'DATE')\n",
            "('2194', 5362, 5366, 'CARDINAL')\n",
            "('1 21', 5367, 5371, 'CARDINAL')\n",
            "('dnr dni', 5380, 5387, 'PERSON')\n",
            "('2194', 5491, 5495, 'CARDINAL')\n",
            "('1 30', 5496, 5500, 'CARDINAL')\n",
            "('2194', 5604, 5608, 'CARDINAL')\n",
            "('2 2', 5609, 5612, 'CARDINAL')\n",
            "('150', 5685, 5688, 'CARDINAL')\n",
            "('4 second', 5762, 5770, 'TIME')\n",
            "('40', 5790, 5792, 'CARDINAL')\n",
            "('micu pt', 5857, 5864, 'GPE')\n",
            "('1 30', 5940, 5944, 'CARDINAL')\n",
            "('20 seconds', 5969, 5979, 'TIME')\n",
            "('3', 6129, 6130, 'CARDINAL')\n",
            "('1', 6141, 6142, 'CARDINAL')\n",
            "('1', 6148, 6149, 'CARDINAL')\n",
            "('10', 6180, 6182, 'CARDINAL')\n",
            "('10', 6242, 6244, 'CARDINAL')\n",
            "('1', 6256, 6257, 'CARDINAL')\n",
            "('1 25', 6283, 6287, 'CARDINAL')\n",
            "('prbc', 6306, 6310, 'GPE')\n",
            "('24', 6328, 6330, 'CARDINAL')\n",
            "('2194', 6343, 6347, 'CARDINAL')\n",
            "('1 12', 6348, 6352, 'CARDINAL')\n",
            "('250 cc', 6445, 6451, 'QUANTITY')\n",
            "('vanc piptaz', 6837, 6848, 'PERSON')\n",
            "('1 22', 6857, 6861, 'CARDINAL')\n",
            "('1 24', 6958, 6962, 'CARDINAL')\n",
            "('gnr', 6963, 6966, 'PERSON')\n",
            "('148 150', 7037, 7044, 'CARDINAL')\n",
            "('defecit', 7056, 7063, 'ORG')\n",
            "('po intake', 7092, 7101, 'PERSON')\n",
            "('2 22', 7201, 7205, 'CARDINAL')\n",
            "('1 l ns', 7472, 7478, 'QUANTITY')\n",
            "('2194', 7615, 7619, 'CARDINAL')\n",
            "('1 30', 7620, 7624, 'CARDINAL')\n",
            "('100', 7665, 7668, 'CARDINAL')\n",
            "('po intake diuresis', 8170, 8188, 'PERSON')\n",
            "('1 9 positive pt', 8319, 8334, 'DATE')\n",
            "('ceftazidime days', 8364, 8380, 'DATE')\n",
            "('1 19', 8397, 8401, 'CARDINAL')\n",
            "('1 22', 8432, 8436, 'DATE')\n",
            "('diurese', 8901, 8908, 'NORP')\n",
            "('micu development', 8909, 8925, 'ORG')\n",
            "('2194', 8988, 8992, 'CARDINAL')\n",
            "('1 17', 8993, 8997, 'CARDINAL')\n",
            "('1 20', 9008, 9012, 'CARDINAL')\n",
            "('retic', 9157, 9162, 'NORP')\n",
            "('1', 9336, 9337, 'CARDINAL')\n",
            "('100 mg 3', 9383, 9391, 'QUANTITY')\n",
            "('4', 9415, 9416, 'CARDINAL')\n",
            "('325 mg', 9472, 9478, 'QUANTITY')\n",
            "('6', 9485, 9486, 'CARDINAL')\n",
            "('3 300 30 mg qid prn 7', 9503, 9524, 'QUANTITY')\n",
            "('12', 9628, 9630, 'CARDINAL')\n",
            "('1', 9665, 9666, 'CARDINAL')\n",
            "('2', 9702, 9703, 'CARDINAL')\n",
            "('3', 9758, 9759, 'CARDINAL')\n",
            "('1 mg po', 9771, 9778, 'MONEY')\n",
            "('daily', 9779, 9784, 'DATE')\n",
            "('daily', 9810, 9815, 'DATE')\n",
            "('1 neb ih 6', 9842, 9852, 'QUANTITY')\n",
            "('tab po', 9895, 9901, 'PERSON')\n",
            "('8', 9919, 9920, 'CARDINAL')\n",
            "('100 mg po', 9937, 9946, 'QUANTITY')\n",
            "('9 albuterol neb soln', 9951, 9971, 'MONEY')\n",
            "('1 neb ih prn', 9972, 9984, 'QUANTITY')\n",
            "('10', 10000, 10002, 'CARDINAL')\n",
            "('500 mg', 10024, 10030, 'QUANTITY')\n",
            "('11', 10034, 10036, 'CARDINAL')\n",
            "('25 mcg hr', 10052, 10061, 'QUANTITY')\n",
            "('12', 10065, 10067, 'CARDINAL')\n",
            "('5', 10078, 10079, 'CARDINAL')\n",
            "('1', 10086, 10087, 'CARDINAL')\n",
            "('12 hours', 10119, 10127, 'TIME')\n",
            "('13', 10135, 10137, 'CARDINAL')\n",
            "('1', 10151, 10152, 'CARDINAL')\n",
            "('2194', 10269, 10273, 'CARDINAL')\n",
            "('2 2', 10274, 10277, 'CARDINAL')\n",
            "('2194', 10436, 10440, 'CARDINAL')\n",
            "('2 2', 10441, 10444, 'CARDINAL')\n",
            "('2194', 10484, 10488, 'CARDINAL')\n",
            "('2 2', 10489, 10492, 'CARDINAL')\n",
            "('2194', 10531, 10535, 'CARDINAL')\n",
            "('md md md 292', 10549, 10561, 'GPE')\n"
          ]
        }
      ],
      "source": [
        "spacy_nlp = load_nlp_model(\"en_core_web_md\")\n",
        "\n",
        "# Get E. coli infection discharge summaries\n",
        "ecoli_df = discharge_summaries_df[discharge_summaries_df['ICD9_CODE'] == '03842']\n",
        "\n",
        "# Preprocess text for E. coli infection discharge summaries using spacy\n",
        "ecoli_df['SPACY_PROCESSED_TEXT'] = ecoli_df['TEXT'].apply(lambda text: tokenize_text(text, \"en_core_web_md\"))\n",
        "\n",
        "# Extract entities from E. coli infection df's first discharge summary\n",
        "entities = extract_entities(ecoli_df.iloc[0]['SPACY_PROCESSED_TEXT'], \"en_core_web_md\")\n",
        "\n",
        "# Print entities\n",
        "for entity in entities:\n",
        "    print(entity)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "aZwuPceJKGRV",
        "outputId": "30e3a1d6-b182-4560-bf1f-5d996634cbea"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">admission date \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " 1 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " discharge date \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2 2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " service medicine allergies patient recorded having known allergies drugs \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    290\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " chief complaint altered mental status hypotension major surgical invasive procedure history present illness \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    age 90\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " f \n",
              "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    russian\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
              "</mark>\n",
              " speaking h o refractory nodular sclerosing hodgkins lymphoma brought \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ems\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " admitted home health care aide noted hypotensive confused ed t rectal hr \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    101 bp\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " rr \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    20 98\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " incontinant guaiac positive stool treated \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4 l ns vanco 1 g\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " iv ceftazadime \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 g\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " iv flagyl \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    500 mg\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " iv received \n",
              "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mg ativan 2 mg\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
              "</mark>\n",
              " iv morphine agitation pt admitted hospital unit \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    153\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " completed \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10 day\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " course ceftazadime vancomycin urosepsis \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    7 day\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " course metronidazole completed empiric treatment diff given loose stools setting elevated wbc count diff assays negative pt stabilized transferred floor care time transfer active issues poor nutritional status thrombocytopenia anemia floor pt experienced episode new afib rvr hypotension sbp \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    90\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " respiratory distress received fluid resuscitation concern tachy \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    brady\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " syndrome pauses \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sec\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " telemetry ep curbside felt digoxin recommended pt readmitted \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " started vancomycin piperacillin tazobactam \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " sites possible infection erosions breasts right hip question pna \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " rising wbc reaching high nearly \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    17\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " course marked \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " hypotension responded gentle ns boluses \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " low uop believed 2 22 hypovolemia low baseline nitrogenous load obligate urine output \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " recurrent afib transitioned amiodarone \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    400 mg po\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">MONEY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " run \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    7 days\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " titrating downward past medical history nodular sclerosing hodgkins lymphoma inguinal lymphadenopathy treated local radiotherapy initially good results \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8 23\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    progression treated cytoxan velban\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " prednisone good response mass sacrum treated radiation therapy severe hypoxemia somnolence generalized edema anasarca responsive diuresis oxygen supplements discharged constant oxygen cvvp trial stopped \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10 28\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " low blood counts dose modified regimen chlorambucil \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4 mg\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " daily days \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 27\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " procarbazine \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    50 mg\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">MONEY</span>\n",
              "</mark>\n",
              " daily days 1 27 \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    velban\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " 10 mg iv day 1 neulasta 6 mg day 8 chemotherapy discontinued given poor response l sided chest pain lytic lesions thoracic vertebrae received radiation therapy including right rib interval decrease vertebral lesions lower extremity cellulitis gerd arthritis chronic ble edema hypothyroidism hypertension constipation social history lives home health care aide son \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ni\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " involved care children tobacco alcohol illicit drug use family history noncontributory physical exam initial physical exam general elderly female acute distress minimally reponsive verbal stimuli responsive tactile stimulation vitals t rectal hr \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    79 bp\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " rr 15 sat \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    nc heent\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sclera anicteric\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " moist mucous membranes neck \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " carotid pulses jvp elevation chest lungs clear anteriorly laterally axillary lad heart regular murmurs \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    abd\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " soft non distended quiet bowel sounds non tender percussion ext pitting edema feet bilaterally nonpalpable pulses feet cool reasonable capillary refill bilaterally neuro sleepy arousable pupils \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 2 mm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " bilaterally withdraws painful stimuli good strength increased tone mute reflexes bilaterally toes mute bilaterally physical exam time transfer medical floor vitals t p 96 r \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    24 94\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " nc general elderly female acute distress minimally reponsive verbal stimuli arousable tactile stimulation heent sclera anicteric dry mucous membranes neck \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " carotid pulses lad jvp elevation chest diminished breath sounds bases bilaterally axillary lad heart regular murmurs \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    abd\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " soft distended active bowel sounds non tender percussion ext pitting edema extremities bilaterally nonpalpable pulses feet cool reasonable capillary refill bilaterally neuro sleepy arousable pupils \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3 4 mm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " bilaterally withdraws painful stimuli diminished reflexes bilaterally physical exam transfer \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " vs temp bp hr \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    102\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " rr \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    31 94\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " 2 lnc gen pleasant comfortable nad somewhat somnolent falling asleep exam \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    heent perrl eomi anicteric tachy mm op\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " lesions neck supraclavicular cervical lymphadenopathy jvd resp occ crackle bases difficult assess b c patient cooperative exam cv rr m r g abd nd b s soft nt masses hepatosplenomegaly ext warm anasarca involvement upper limbs skin rashes jaundice neuro somewhat somnolent cn ii xii grossly intact difficult complete neuro exam given somnolence pertinent results \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " cxr impression persistent right sided effusion definite consolidation routine pa lateral films recommended evaluation feasible \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 10\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " echo left atrium normal size atrial septal defect seen color doppler left ventricular wall thicknesses normal left ventricular cavity size normal overall left ventricular systolic function normal right ventricular chamber size free wall motion normal aortic valve leaflets probably \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mildly thickened aortic valve stenosis trace aortic regurgitation seen mitral valve leaflets mildly thickened physiologic mitral regurgitation seen normal limits moderate pulmonary artery systolic hypertension pericardial effusion based \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2193\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " aha endocarditis prophylaxis recommendations echo findings indicate prophylaxis recommended clinical decisions need prophylaxis based clinical echocardiographic data compared report prior study images unavailable review 2190 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12 22\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " definite change brief hospital course \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    age 90\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " f nodular sclerosing hodgkin lymphoma initially admitted urosepsis transferred icu hypotension afib rvr goals care patient long hospital course family meetings reagarding goals care \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 21\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " patient \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    dnr dni\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " family continued want icu transfers pressors needed regardless comfort patient patient tranferred unit \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 30\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " started levophed hypotension eventually decision medically futile escalate care care escalated expired \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2 2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " family declined autopsy afib rvr pt experienced transient episodes afib \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    150\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " controlled diltiazem metoprolol spontaneous conversion multiple episodes \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4 second\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " pauses bradycardia \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    40\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " likely junctional escape digoxin considered unfavorable patient \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu pt\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " started amiodarone gtt converted amiodarone po patient readmitted icu 2194 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 30\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " having increased pauses \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    20 seconds\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " amiodarone stopped thrombocytopenia anemia patient anemia thrombocytopenic admission thought secondary marrow infiltration lymphoma transfused total \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " units plt \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " unit \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " 14 1 19 transfusion threshold \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " continue trend platelets transfuse bleeding platelet count \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " transfused \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " unit platelets good bump \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 25\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " patient receiving \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prbc\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " transfusions hct \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    24\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " total units \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " hypotension early admission having hypotensive episodes furosemide responsive fluid blosues \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    250 cc\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " echo demonstrated impaired lv relaxation given elevated wbc concern distributive shock longer fluid responsive started phenylephrine gtt weaned hypotension later admission thought secondary systemic vasodilation started levophed decision escalate care infection wbc elevated multiple possible infectious sources contribute hypotension ie skin erosions breasts course breath sounds pna \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    vanc piptaz\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " started \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 22\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " cultures blood urine pending sputum obtainable point cdiff repeated toxin c diff neg d c flagyl \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 24\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    gnr\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " skin swab hypernatremia noted periodically hypernatremic admission na \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    148 150\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " free water \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    defecit\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " getting slow infusions poor \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    po intake\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " able free water intake altered mental status increased lethargy compared baseline admission likely \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2 22\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " metabolic encephalopathy infection acute renal failure slight improvement resolution urosepsis head ct negative acute process thyroid studies elevated tsh c w sick euthyroid syndrome respiratory distress early admission patient developed labored breathing receiving \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 l ns\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " hypotension c w flash pulmonary edema diuresis furosemide gtt lead hypotension albumin resuscitation lead repeated respiratory distress \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 30\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " floor witnessed aspiration event needed \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " hi flow mask icu weaned aspirated increasing requirements acute renal failure pt noted cr admission presumed baseline returned baseline likely pre renal dehydration hypotension sepsis later hospital course patient hypotensive creatinine began rise thought secondary atn hypothyroidism initially treated levothyroxine mcg iv daily half home dose low tsh elevated resumed home dose anasarca pt diffuse edema large bilateral pleural effusions likely spacing malnutrition given low albumin admission poor \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    po intake diuresis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " difficult hypotension detailed continue monitor urosepsis admitted hypotension urosepsis requiring pressor support urine cultures \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 9 positive pt\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " completed treated vancomycin \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ceftazidime days\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " repeat ucx 2194 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 19\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " grew yeast treated repeat ucx \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 22\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " final grew yeast right hip pain pain destruction right acetabulum consistent progressive lymphoma ct scan dramatic medial displacement right femoral head secondary lack remaining osseous support stable destruction right posterior sacroiliac joint surrounding right sacral ala iliac bone patient pain controlled fentanyl lidocaine patches bilateral pleural effusion r l thought likely agressive hydration setting sepsis hypoalbuminemia difficult effect significant \n",
              "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    diurese\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu development\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " hypotension response furosemide appears slightly improved cxr \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 17\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " unchanged \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 20\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " cxr nodular sclerosing hodgkin lymphoma seen oncology interventions time likely bone marrow infiltration causing anemia thrombocytopenia pt low \n",
              "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    retic\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
              "</mark>\n",
              " count evidence hemolysis treatment oncology coagulopathy mild likely nutritional deficiency encourage po intake trend lfts coags medications admission medications admission \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " levothyroxine 25 mcg daily 2 docusate sodium \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100 mg 3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " omeprazole 20 mg daily \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " oxycodone acetaminophen 5 325 mg prn 5 ferrous sulfate \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    325 mg\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " daily \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " tylenol codeine \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3 300 30 mg qid prn 7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " ultram 50 mg 4 6 hours 8 lasix 20 mg daily 9 senna mg prn 10 aspirin 81 mg daily 11 potassium chloride \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " multivitamin medications transfer \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " acetaminophen 325 650 mg po pr prn \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " miconazole powder 2 1 appl tp tid apply affected area \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " folic acid \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 mg po\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">MONEY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " 4 multivitamins 1 cap po \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " 5 ipratropium bromide neb \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 neb ih 6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " bisacodyl 10 mg po pr daily prn 7 senna 1 \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tab po\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " bid constipation \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " docusate sodium \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100 mg po\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " bid \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    9 albuterol neb soln\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">MONEY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1 neb ih prn\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " wheezing cough \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " metronidazole flagyl \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    500 mg\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " iv \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    11\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " fentanyl patch \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    25 mcg hr\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " tp \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " lidocaine \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " patch \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " ptch td qd apply right hip day \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12 hours\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " remove \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    13\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " sarna lotion \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " appl tp tid prn 14 levothyroxine sodium mcg iv daily 15 pantoprazole 40 mg iv discharge medications patient expired \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2 2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " discharge disposition extended care discharge diagnosis urosepsis aspiration pneumonitis atrial fibrillation rvr lymphoma discharge condition patient expired \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2 2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " discharge instructions patient expired \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2 2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " followup instructions patient expired \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2194\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " 2 2 initials \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    md md md 292\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              "</div></span>"
            ],
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "*********************************************************************************************************************************************************************\n"
          ]
        }
      ],
      "source": [
        "# Visualize entities in the first discharge summary PROCESSED_TEXT\n",
        "doc = spacy_nlp(ecoli_df['SPACY_PROCESSED_TEXT'].iloc[0])\n",
        "displacy.render(doc, style=\"ent\", jupyter=True)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# SciSpacy Named Entity Recognition (NER)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/var/folders/wd/pkw1ts416gsg2fjyp1rgznqc0000gn/T/ipykernel_96334/1406973440.py:8: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  ecoli_df['SCISPACY_PROCESSED_TEXT'] = ecoli_df['TEXT'].apply(lambda text: tokenize_text(text, \"en_core_sci_md\"))\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "('admission', 0, 9, 'ENTITY')\n",
            "*****************\n",
            "('discharge', 24, 33, 'ENTITY')\n",
            "*****************\n",
            "('service medicine', 48, 64, 'ENTITY')\n",
            "*****************\n",
            "('patient', 75, 82, 'ENTITY')\n",
            "*****************\n",
            "('allergies drugs', 105, 120, 'ENTITY')\n",
            "*****************\n",
            "('chief complaint', 125, 140, 'ENTITY')\n",
            "*****************\n",
            "('mental status', 149, 162, 'ENTITY')\n",
            "*****************\n",
            "('hypotension', 163, 174, 'ENTITY')\n",
            "*****************\n",
            "('surgical invasive procedure history', 181, 216, 'ENTITY')\n",
            "*****************\n",
            "('illness age', 225, 236, 'ENTITY')\n",
            "*****************\n",
            "('refractory', 242, 252, 'ENTITY')\n",
            "*****************\n",
            "('hodgkins lymphoma', 272, 289, 'ENTITY')\n",
            "*****************\n",
            "('ems', 298, 301, 'ENTITY')\n",
            "*****************\n",
            "('hypotensive', 339, 350, 'ENTITY')\n",
            "*****************\n",
            "('incontinant', 391, 402, 'ENTITY')\n",
            "*****************\n",
            "('stool', 403, 408, 'ENTITY')\n",
            "*****************\n",
            "('treated', 409, 416, 'ENTITY')\n",
            "*****************\n",
            "('vanco', 424, 429, 'ENTITY')\n",
            "*****************\n",
            "('ativan', 485, 491, 'ENTITY')\n",
            "*****************\n",
            "('morphine', 500, 508, 'ENTITY')\n",
            "*****************\n",
            "('agitation', 509, 518, 'ENTITY')\n",
            "*****************\n",
            "('admitted hospital unit', 522, 544, 'ENTITY')\n",
            "*****************\n",
            "('course', 559, 565, 'ENTITY')\n",
            "*****************\n",
            "('ceftazadime', 566, 577, 'ENTITY')\n",
            "*****************\n",
            "('vancomycin', 578, 588, 'ENTITY')\n",
            "*****************\n",
            "('urosepsis', 589, 598, 'ENTITY')\n",
            "*****************\n",
            "('course', 599, 605, 'ENTITY')\n",
            "*****************\n",
            "('metronidazole', 606, 619, 'ENTITY')\n",
            "*****************\n",
            "('empiric treatment', 630, 647, 'ENTITY')\n",
            "*****************\n",
            "('loose stools', 659, 671, 'ENTITY')\n",
            "*****************\n",
            "('elevated', 680, 688, 'ENTITY')\n",
            "*****************\n",
            "('wbc count diff assays', 689, 710, 'ENTITY')\n",
            "*****************\n",
            "('negative', 711, 719, 'ENTITY')\n",
            "*****************\n",
            "('stabilized', 723, 733, 'ENTITY')\n",
            "*****************\n",
            "('transferred floor', 734, 751, 'ENTITY')\n",
            "*****************\n",
            "('time transfer', 757, 770, 'ENTITY')\n",
            "*****************\n",
            "('active issues', 771, 784, 'ENTITY')\n",
            "*****************\n",
            "('nutritional status thrombocytopenia', 790, 825, 'ENTITY')\n",
            "*****************\n",
            "('anemia', 826, 832, 'ENTITY')\n",
            "*****************\n",
            "('floor', 833, 838, 'ENTITY')\n",
            "*****************\n",
            "('episode', 854, 861, 'ENTITY')\n",
            "*****************\n",
            "('afib rvr', 866, 874, 'ENTITY')\n",
            "*****************\n",
            "('hypotension', 875, 886, 'ENTITY')\n",
            "*****************\n",
            "('respiratory distress', 894, 914, 'ENTITY')\n",
            "*****************\n",
            "('fluid resuscitation concern syndrome', 924, 960, 'ENTITY')\n",
            "*****************\n",
            "('pauses', 961, 967, 'ENTITY')\n",
            "*****************\n",
            "('digoxin', 1001, 1008, 'ENTITY')\n",
            "*****************\n",
            "('readmitted', 1024, 1034, 'ENTITY')\n",
            "*****************\n",
            "('micu', 1035, 1039, 'ENTITY')\n",
            "*****************\n",
            "('micu', 1040, 1044, 'ENTITY')\n",
            "*****************\n",
            "('vancomycin', 1053, 1063, 'ENTITY')\n",
            "*****************\n",
            "('sites', 1066, 1071, 'ENTITY')\n",
            "*****************\n",
            "('infection', 1081, 1090, 'ENTITY')\n",
            "*****************\n",
            "('erosions', 1091, 1099, 'ENTITY')\n",
            "*****************\n",
            "('breasts right', 1100, 1113, 'ENTITY')\n",
            "*****************\n",
            "('micu', 1168, 1172, 'ENTITY')\n",
            "*****************\n",
            "('course', 1173, 1179, 'ENTITY')\n",
            "*****************\n",
            "('hypotension', 1189, 1200, 'ENTITY')\n",
            "*****************\n",
            "('low', 1231, 1234, 'ENTITY')\n",
            "*****************\n",
            "('hypovolemia', 1253, 1264, 'ENTITY')\n",
            "*****************\n",
            "('baseline', 1269, 1277, 'ENTITY')\n",
            "*****************\n",
            "('nitrogenous urine output', 1278, 1302, 'ENTITY')\n",
            "*****************\n",
            "('amiodarone', 1333, 1343, 'ENTITY')\n",
            "*****************\n",
            "('daily', 1354, 1359, 'ENTITY')\n",
            "*****************\n",
            "('days', 1366, 1370, 'ENTITY')\n",
            "*****************\n",
            "('downward', 1381, 1389, 'ENTITY')\n",
            "*****************\n",
            "('medical history', 1395, 1410, 'ENTITY')\n",
            "*****************\n",
            "('nodular sclerosing', 1411, 1429, 'ENTITY')\n",
            "*****************\n",
            "('hodgkins lymphoma', 1430, 1447, 'ENTITY')\n",
            "*****************\n",
            "('lymphadenopathy', 1457, 1472, 'ENTITY')\n",
            "*****************\n",
            "('treated', 1473, 1480, 'ENTITY')\n",
            "*****************\n",
            "('local radiotherapy', 1481, 1499, 'ENTITY')\n",
            "*****************\n",
            "('progression', 1528, 1539, 'ENTITY')\n",
            "*****************\n",
            "('treated', 1540, 1547, 'ENTITY')\n",
            "*****************\n",
            "('cytoxan', 1548, 1555, 'ENTITY')\n",
            "*****************\n",
            "('prednisone', 1563, 1573, 'ENTITY')\n",
            "*****************\n",
            "('treated', 1600, 1607, 'ENTITY')\n",
            "*****************\n",
            "('radiation therapy', 1608, 1625, 'ENTITY')\n",
            "*****************\n",
            "('hypoxemia somnolence generalized edema anasarca', 1633, 1680, 'ENTITY')\n",
            "*****************\n",
            "('discharged constant', 1720, 1739, 'ENTITY')\n",
            "*****************\n",
            "('trial', 1752, 1757, 'ENTITY')\n",
            "*****************\n",
            "('low blood counts', 1772, 1788, 'ENTITY')\n",
            "*****************\n",
            "('chlorambucil', 1806, 1818, 'ENTITY')\n",
            "*****************\n",
            "('daily', 1824, 1829, 'ENTITY')\n",
            "*****************\n",
            "('days', 1830, 1834, 'ENTITY')\n",
            "*****************\n",
            "('procarbazine', 1840, 1852, 'ENTITY')\n",
            "*****************\n",
            "('daily', 1859, 1864, 'ENTITY')\n",
            "*****************\n",
            "('days', 1865, 1869, 'ENTITY')\n",
            "*****************\n",
            "('velban', 1875, 1881, 'ENTITY')\n",
            "*****************\n",
            "('day', 1911, 1914, 'ENTITY')\n",
            "*****************\n",
            "('chemotherapy', 1917, 1929, 'ENTITY')\n",
            "*****************\n",
            "('poor response', 1949, 1962, 'ENTITY')\n",
            "*****************\n",
            "('sided chest', 1965, 1976, 'ENTITY')\n",
            "*****************\n",
            "('lytic lesions', 1982, 1995, 'ENTITY')\n",
            "*****************\n",
            "('radiation therapy', 2024, 2041, 'ENTITY')\n",
            "*****************\n",
            "('right rib interval', 2052, 2070, 'ENTITY')\n",
            "*****************\n",
            "('decrease', 2071, 2079, 'ENTITY')\n",
            "*****************\n",
            "('vertebral lesions', 2080, 2097, 'ENTITY')\n",
            "*****************\n",
            "('lower extremity cellulitis', 2098, 2124, 'ENTITY')\n",
            "*****************\n",
            "('gerd arthritis', 2125, 2139, 'ENTITY')\n",
            "*****************\n",
            "('chronic ble edema hypothyroidism', 2140, 2172, 'ENTITY')\n",
            "*****************\n",
            "('constipation', 2186, 2198, 'ENTITY')\n",
            "*****************\n",
            "('social history', 2199, 2213, 'ENTITY')\n",
            "*****************\n",
            "('home health care', 2220, 2236, 'ENTITY')\n",
            "*****************\n",
            "('son ni', 2242, 2248, 'ENTITY')\n",
            "*****************\n",
            "('care children', 2258, 2271, 'ENTITY')\n",
            "*****************\n",
            "('alcohol illicit drug', 2280, 2300, 'ENTITY')\n",
            "*****************\n",
            "('family history', 2305, 2319, 'ENTITY')\n",
            "*****************\n",
            "('noncontributory', 2320, 2335, 'ENTITY')\n",
            "*****************\n",
            "('physical exam', 2336, 2349, 'ENTITY')\n",
            "*****************\n",
            "('physical exam', 2358, 2371, 'ENTITY')\n",
            "*****************\n",
            "('elderly', 2380, 2387, 'ENTITY')\n",
            "*****************\n",
            "('female', 2388, 2394, 'ENTITY')\n",
            "*****************\n",
            "('minimally reponsive verbal stimuli', 2410, 2444, 'ENTITY')\n",
            "*****************\n",
            "('tactile', 2456, 2463, 'ENTITY')\n",
            "*****************\n",
            "('stimulation', 2464, 2475, 'ENTITY')\n",
            "*****************\n",
            "('moist', 2537, 2542, 'ENTITY')\n",
            "*****************\n",
            "('mucous membranes', 2543, 2559, 'ENTITY')\n",
            "*****************\n",
            "('carotid pulses', 2567, 2581, 'ENTITY')\n",
            "*****************\n",
            "('lungs', 2602, 2607, 'ENTITY')\n",
            "*****************\n",
            "('abd soft', 2670, 2678, 'ENTITY')\n",
            "*****************\n",
            "('non tender percussion ext pitting edema feet bilaterally nonpalpable', 2712, 2780, 'ENTITY')\n",
            "*****************\n",
            "('capillary refill bilaterally neuro', 2809, 2843, 'ENTITY')\n",
            "*****************\n",
            "('pupils', 2861, 2867, 'ENTITY')\n",
            "*****************\n",
            "('bilaterally', 2875, 2886, 'ENTITY')\n",
            "*****************\n",
            "('painful', 2897, 2904, 'ENTITY')\n",
            "*****************\n",
            "('increased', 2927, 2936, 'ENTITY')\n",
            "*****************\n",
            "('tone mute', 2937, 2946, 'ENTITY')\n",
            "*****************\n",
            "('bilaterally toes', 2956, 2972, 'ENTITY')\n",
            "*****************\n",
            "('physical exam', 2990, 3003, 'ENTITY')\n",
            "*****************\n",
            "('time transfer', 3004, 3017, 'ENTITY')\n",
            "*****************\n",
            "('elderly', 3065, 3072, 'ENTITY')\n",
            "*****************\n",
            "('female', 3073, 3079, 'ENTITY')\n",
            "*****************\n",
            "('minimally reponsive verbal stimuli', 3095, 3129, 'ENTITY')\n",
            "*****************\n",
            "('tactile', 3140, 3147, 'ENTITY')\n",
            "*****************\n",
            "('dry mucous membranes', 3183, 3203, 'ENTITY')\n",
            "*****************\n",
            "('carotid pulses', 3211, 3225, 'ENTITY')\n",
            "*****************\n",
            "('jvp', 3230, 3233, 'ENTITY')\n",
            "*****************\n",
            "('breath sounds bases', 3261, 3280, 'ENTITY')\n",
            "*****************\n",
            "('bilaterally', 3281, 3292, 'ENTITY')\n",
            "*****************\n",
            "('abd soft distended', 3328, 3346, 'ENTITY')\n",
            "*****************\n",
            "('active bowel sounds', 3347, 3366, 'ENTITY')\n",
            "*****************\n",
            "('non tender percussion ext pitting edema extremities', 3367, 3418, 'ENTITY')\n",
            "*****************\n",
            "('bilaterally nonpalpable', 3419, 3442, 'ENTITY')\n",
            "*****************\n",
            "('capillary refill bilaterally neuro', 3471, 3505, 'ENTITY')\n",
            "*****************\n",
            "('pupils 3 4', 3523, 3533, 'ENTITY')\n",
            "*****************\n",
            "('bilaterally', 3537, 3548, 'ENTITY')\n",
            "*****************\n",
            "('painful', 3559, 3566, 'ENTITY')\n",
            "*****************\n",
            "('stimuli', 3567, 3574, 'ENTITY')\n",
            "*****************\n",
            "('reflexes bilaterally physical exam transfer', 3586, 3629, 'ENTITY')\n",
            "*****************\n",
            "('micu', 3630, 3634, 'ENTITY')\n",
            "*****************\n",
            "('temp bp', 3638, 3645, 'ENTITY')\n",
            "*****************\n",
            "('lnc', 3664, 3667, 'ENTITY')\n",
            "*****************\n",
            "('gen pleasant comfortable nad', 3668, 3696, 'ENTITY')\n",
            "*****************\n",
            "('somnolent', 3706, 3715, 'ENTITY')\n",
            "*****************\n",
            "('heent', 3736, 3741, 'ENTITY')\n",
            "*****************\n",
            "('eomi', 3748, 3752, 'ENTITY')\n",
            "*****************\n",
            "('anicteric tachy', 3753, 3768, 'ENTITY')\n",
            "*****************\n",
            "('lesions', 3775, 3782, 'ENTITY')\n",
            "*****************\n",
            "('neck supraclavicular cervical lymphadenopathy jvd resp occ crackle bases', 3783, 3855, 'ENTITY')\n",
            "*****************\n",
            "('patient', 3873, 3880, 'ENTITY')\n",
            "*****************\n",
            "('cooperative exam', 3881, 3897, 'ENTITY')\n",
            "*****************\n",
            "('involvement', 3963, 3974, 'ENTITY')\n",
            "*****************\n",
            "('upper limbs', 3975, 3986, 'ENTITY')\n",
            "*****************\n",
            "('skin rashes', 3987, 3998, 'ENTITY')\n",
            "*****************\n",
            "('jaundice neuro', 3999, 4013, 'ENTITY')\n",
            "*****************\n",
            "('somnolent', 4023, 4032, 'ENTITY')\n",
            "*****************\n",
            "('neuro', 4070, 4075, 'ENTITY')\n",
            "*****************\n",
            "('somnolence pertinent results', 4087, 4115, 'ENTITY')\n",
            "*****************\n",
            "('consolidation', 4164, 4177, 'ENTITY')\n",
            "*****************\n",
            "('routine', 4178, 4185, 'ENTITY')\n",
            "*****************\n",
            "('pa lateral', 4186, 4196, 'ENTITY')\n",
            "*****************\n",
            "('films', 4197, 4202, 'ENTITY')\n",
            "*****************\n",
            "('evaluation', 4215, 4225, 'ENTITY')\n",
            "*****************\n",
            "('echo left atrium', 4240, 4256, 'ENTITY')\n",
            "*****************\n",
            "('atrial septal defect', 4269, 4289, 'ENTITY')\n",
            "*****************\n",
            "('color', 4295, 4300, 'ENTITY')\n",
            "*****************\n",
            "('doppler left ventricular wall', 4301, 4330, 'ENTITY')\n",
            "*****************\n",
            "('left ventricular cavity', 4350, 4373, 'ENTITY')\n",
            "*****************\n",
            "('left ventricular systolic function', 4394, 4428, 'ENTITY')\n",
            "*****************\n",
            "('free wall motion normal', 4467, 4490, 'ENTITY')\n",
            "*****************\n",
            "('valve leaflets', 4498, 4512, 'ENTITY')\n",
            "*****************\n",
            "('trace aortic regurgitation', 4563, 4589, 'ENTITY')\n",
            "*****************\n",
            "('mitral valve leaflets', 4595, 4616, 'ENTITY')\n",
            "*****************\n",
            "('physiologic', 4634, 4645, 'ENTITY')\n",
            "*****************\n",
            "('mitral regurgitation', 4646, 4666, 'ENTITY')\n",
            "*****************\n",
            "('pulmonary artery', 4695, 4711, 'ENTITY')\n",
            "*****************\n",
            "('pericardial effusion', 4734, 4754, 'ENTITY')\n",
            "*****************\n",
            "('endocarditis', 4770, 4782, 'ENTITY')\n",
            "*****************\n",
            "('prophylaxis', 4783, 4794, 'ENTITY')\n",
            "*****************\n",
            "('recommendations', 4795, 4810, 'ENTITY')\n",
            "*****************\n",
            "('echo findings', 4811, 4824, 'ENTITY')\n",
            "*****************\n",
            "('prophylaxis', 4834, 4845, 'ENTITY')\n",
            "*****************\n",
            "('clinical decisions', 4858, 4876, 'ENTITY')\n",
            "*****************\n",
            "('prophylaxis', 4882, 4893, 'ENTITY')\n",
            "*****************\n",
            "('clinical', 4900, 4908, 'ENTITY')\n",
            "*****************\n",
            "('echocardiographic', 4909, 4926, 'ENTITY')\n",
            "*****************\n",
            "('data', 4927, 4931, 'ENTITY')\n",
            "*****************\n",
            "('study images', 4954, 4966, 'ENTITY')\n",
            "*****************\n",
            "('review', 4979, 4985, 'ENTITY')\n",
            "*****************\n",
            "('hospital course', 5019, 5034, 'ENTITY')\n",
            "*****************\n",
            "('age', 5035, 5038, 'ENTITY')\n",
            "*****************\n",
            "('nodular sclerosing hodgkin lymphoma', 5044, 5079, 'ENTITY')\n",
            "*****************\n",
            "('urosepsis', 5099, 5108, 'ENTITY')\n",
            "*****************\n",
            "('icu hypotension', 5121, 5136, 'ENTITY')\n",
            "*****************\n",
            "('goals care', 5146, 5156, 'ENTITY')\n",
            "*****************\n",
            "('patient', 5157, 5164, 'ENTITY')\n",
            "*****************\n",
            "('long hospital course', 5165, 5185, 'ENTITY')\n",
            "*****************\n",
            "('family meetings reagarding', 5186, 5212, 'ENTITY')\n",
            "*****************\n",
            "('goals care', 5213, 5223, 'ENTITY')\n",
            "*****************\n",
            "('patient', 5234, 5241, 'ENTITY')\n",
            "*****************\n",
            "('icu transfers', 5264, 5277, 'ENTITY')\n",
            "*****************\n",
            "('pressors', 5278, 5286, 'ENTITY')\n",
            "*****************\n",
            "('comfort', 5305, 5312, 'ENTITY')\n",
            "*****************\n",
            "('patient', 5313, 5320, 'ENTITY')\n",
            "*****************\n",
            "('patient', 5321, 5328, 'ENTITY')\n",
            "*****************\n",
            "('levophed hypotension', 5363, 5383, 'ENTITY')\n",
            "*****************\n",
            "('decision medically futile', 5395, 5420, 'ENTITY')\n",
            "*****************\n",
            "('escalate care care', 5421, 5439, 'ENTITY')\n",
            "*****************\n",
            "('family', 5467, 5473, 'ENTITY')\n",
            "*****************\n",
            "('autopsy', 5483, 5490, 'ENTITY')\n",
            "*****************\n",
            "('afib', 5491, 5495, 'ENTITY')\n",
            "*****************\n",
            "('transient', 5515, 5524, 'ENTITY')\n",
            "*****************\n",
            "('controlled', 5543, 5553, 'ENTITY')\n",
            "*****************\n",
            "('diltiazem', 5554, 5563, 'ENTITY')\n",
            "*****************\n",
            "('metoprolol', 5564, 5574, 'ENTITY')\n",
            "*****************\n",
            "('spontaneous', 5575, 5586, 'ENTITY')\n",
            "*****************\n",
            "('conversion', 5587, 5597, 'ENTITY')\n",
            "*****************\n",
            "('pauses', 5625, 5631, 'ENTITY')\n",
            "*****************\n",
            "('bradycardia', 5632, 5643, 'ENTITY')\n",
            "*****************\n",
            "('junctional escape', 5654, 5671, 'ENTITY')\n",
            "*****************\n",
            "('digoxin', 5672, 5679, 'ENTITY')\n",
            "*****************\n",
            "('patient', 5703, 5710, 'ENTITY')\n",
            "*****************\n",
            "('micu', 5711, 5715, 'ENTITY')\n",
            "*****************\n",
            "('amiodarone', 5727, 5737, 'ENTITY')\n",
            "*****************\n",
            "('gtt', 5738, 5741, 'ENTITY')\n",
            "*****************\n",
            "('amiodarone', 5752, 5762, 'ENTITY')\n",
            "*****************\n",
            "('patient readmitted', 5766, 5784, 'ENTITY')\n",
            "*****************\n",
            "('increased', 5806, 5815, 'ENTITY')\n",
            "*****************\n",
            "('pauses', 5816, 5822, 'ENTITY')\n",
            "*****************\n",
            "('amiodarone', 5834, 5844, 'ENTITY')\n",
            "*****************\n",
            "('patient', 5853, 5860, 'ENTITY')\n",
            "*****************\n",
            "('anemia', 5861, 5867, 'ENTITY')\n",
            "*****************\n",
            "('thrombocytopenic admission', 5868, 5894, 'ENTITY')\n",
            "*****************\n",
            "('secondary marrow infiltration lymphoma', 5903, 5941, 'ENTITY')\n",
            "*****************\n",
            "('transfused', 5942, 5952, 'ENTITY')\n",
            "*****************\n",
            "('plt 1 unit', 5967, 5977, 'ENTITY')\n",
            "*****************\n",
            "('transfusion', 5988, 5999, 'ENTITY')\n",
            "*****************\n",
            "('threshold', 6000, 6009, 'ENTITY')\n",
            "*****************\n",
            "('trend', 6022, 6027, 'ENTITY')\n",
            "*****************\n",
            "('platelets', 6028, 6037, 'ENTITY')\n",
            "*****************\n",
            "('transfuse bleeding', 6038, 6056, 'ENTITY')\n",
            "*****************\n",
            "('platelet count', 6057, 6071, 'ENTITY')\n",
            "*****************\n",
            "('platelets', 6093, 6102, 'ENTITY')\n",
            "*****************\n",
            "('patient', 6118, 6125, 'ENTITY')\n",
            "*****************\n",
            "('prbc transfusions', 6136, 6153, 'ENTITY')\n",
            "*****************\n",
            "('hypotension', 6183, 6194, 'ENTITY')\n",
            "*****************\n",
            "('hypotensive episodes', 6218, 6238, 'ENTITY')\n",
            "*****************\n",
            "('furosemide', 6239, 6249, 'ENTITY')\n",
            "*****************\n",
            "('responsive', 6250, 6260, 'ENTITY')\n",
            "*****************\n",
            "('fluid', 6261, 6266, 'ENTITY')\n",
            "*****************\n",
            "('blosues', 6267, 6274, 'ENTITY')\n",
            "*****************\n",
            "('echo', 6282, 6286, 'ENTITY')\n",
            "*****************\n",
            "('impaired', 6300, 6308, 'ENTITY')\n",
            "*****************\n",
            "('lv relaxation', 6309, 6322, 'ENTITY')\n",
            "*****************\n",
            "('elevated', 6329, 6337, 'ENTITY')\n",
            "*****************\n",
            "('phenylephrine', 6401, 6414, 'ENTITY')\n",
            "*****************\n",
            "('gtt', 6415, 6418, 'ENTITY')\n",
            "*****************\n",
            "('weaned hypotension', 6419, 6437, 'ENTITY')\n",
            "*****************\n",
            "('admission', 6444, 6453, 'ENTITY')\n",
            "*****************\n",
            "('secondary', 6462, 6471, 'ENTITY')\n",
            "*****************\n",
            "('systemic vasodilation', 6472, 6493, 'ENTITY')\n",
            "*****************\n",
            "('levophed decision escalate care infection', 6502, 6543, 'ENTITY')\n",
            "*****************\n",
            "('elevated', 6548, 6556, 'ENTITY')\n",
            "*****************\n",
            "('infectious', 6575, 6585, 'ENTITY')\n",
            "*****************\n",
            "('sources', 6586, 6593, 'ENTITY')\n",
            "*****************\n",
            "('hypotension', 6605, 6616, 'ENTITY')\n",
            "*****************\n",
            "('skin erosions', 6620, 6633, 'ENTITY')\n",
            "*****************\n",
            "('breasts', 6634, 6641, 'ENTITY')\n",
            "*****************\n",
            "('breath sounds pna vanc', 6649, 6671, 'ENTITY')\n",
            "*****************\n",
            "('piptaz', 6672, 6678, 'ENTITY')\n",
            "*****************\n",
            "('cultures', 6692, 6700, 'ENTITY')\n",
            "*****************\n",
            "('blood urine', 6701, 6712, 'ENTITY')\n",
            "*****************\n",
            "('sputum', 6721, 6727, 'ENTITY')\n",
            "*****************\n",
            "('point cdiff', 6739, 6750, 'ENTITY')\n",
            "*****************\n",
            "('flagyl 1', 6777, 6785, 'ENTITY')\n",
            "*****************\n",
            "('skin swab hypernatremia', 6793, 6816, 'ENTITY')\n",
            "*****************\n",
            "('hypernatremic admission', 6836, 6859, 'ENTITY')\n",
            "*****************\n",
            "('free water', 6871, 6881, 'ENTITY')\n",
            "*****************\n",
            "('intake', 6921, 6927, 'ENTITY')\n",
            "*****************\n",
            "('free water', 6933, 6943, 'ENTITY')\n",
            "*****************\n",
            "('mental status', 6959, 6972, 'ENTITY')\n",
            "*****************\n",
            "('increased', 6973, 6982, 'ENTITY')\n",
            "*****************\n",
            "('lethargy', 6983, 6991, 'ENTITY')\n",
            "*****************\n",
            "('baseline admission', 7001, 7019, 'ENTITY')\n",
            "*****************\n",
            "('metabolic encephalopathy', 7032, 7056, 'ENTITY')\n",
            "*****************\n",
            "('respiratory distress', 7211, 7231, 'ENTITY')\n",
            "*****************\n",
            "('admission', 7238, 7247, 'ENTITY')\n",
            "*****************\n",
            "('patient', 7248, 7255, 'ENTITY')\n",
            "*****************\n",
            "('labored breathing', 7266, 7283, 'ENTITY')\n",
            "*****************\n",
            "('ns hypotension flash pulmonary edema diuresis furosemide', 7298, 7354, 'ENTITY')\n",
            "*****************\n",
            "('gtt lead hypotension', 7355, 7375, 'ENTITY')\n",
            "*****************\n",
            "('resuscitation lead', 7384, 7402, 'ENTITY')\n",
            "*****************\n",
            "('respiratory distress', 7412, 7432, 'ENTITY')\n",
            "*****************\n",
            "('floor', 7443, 7448, 'ENTITY')\n",
            "*****************\n",
            "('event', 7470, 7475, 'ENTITY')\n",
            "*****************\n",
            "('flow mask icu', 7490, 7503, 'ENTITY')\n",
            "*****************\n",
            "('weaned', 7504, 7510, 'ENTITY')\n",
            "*****************\n",
            "('increasing', 7521, 7531, 'ENTITY')\n",
            "*****************\n",
            "('requirements', 7532, 7544, 'ENTITY')\n",
            "*****************\n",
            "('acute renal failure', 7545, 7564, 'ENTITY')\n",
            "*****************\n",
            "('cr admission', 7574, 7586, 'ENTITY')\n",
            "*****************\n",
            "('baseline', 7596, 7604, 'ENTITY')\n",
            "*****************\n",
            "('baseline', 7614, 7622, 'ENTITY')\n",
            "*****************\n",
            "('dehydration hypotension sepsis', 7630, 7660, 'ENTITY')\n",
            "*****************\n",
            "('hospital course', 7667, 7682, 'ENTITY')\n",
            "*****************\n",
            "('patient', 7683, 7690, 'ENTITY')\n",
            "*****************\n",
            "('hypotensive creatinine', 7691, 7713, 'ENTITY')\n",
            "*****************\n",
            "('secondary atn hypothyroidism', 7733, 7761, 'ENTITY')\n",
            "*****************\n",
            "('treated', 7772, 7779, 'ENTITY')\n",
            "*****************\n",
            "('levothyroxine', 7780, 7793, 'ENTITY')\n",
            "*****************\n",
            "('elevated', 7830, 7838, 'ENTITY')\n",
            "*****************\n",
            "('home dose', 7847, 7856, 'ENTITY')\n",
            "*****************\n",
            "('anasarca', 7857, 7865, 'ENTITY')\n",
            "*****************\n",
            "('edema', 7877, 7882, 'ENTITY')\n",
            "*****************\n",
            "('bilateral', 7889, 7898, 'ENTITY')\n",
            "*****************\n",
            "('pleural effusions', 7899, 7916, 'ENTITY')\n",
            "*****************\n",
            "('malnutrition', 7924, 7936, 'ENTITY')\n",
            "*****************\n",
            "('low albumin admission', 7943, 7964, 'ENTITY')\n",
            "*****************\n",
            "('intake', 7973, 7979, 'ENTITY')\n",
            "*****************\n",
            "('diuresis', 7980, 7988, 'ENTITY')\n",
            "*****************\n",
            "('difficult', 7989, 7998, 'ENTITY')\n",
            "*****************\n",
            "('hypotension', 7999, 8010, 'ENTITY')\n",
            "*****************\n",
            "('urosepsis', 8037, 8046, 'ENTITY')\n",
            "*****************\n",
            "('admitted', 8047, 8055, 'ENTITY')\n",
            "*****************\n",
            "('hypotension urosepsis', 8056, 8077, 'ENTITY')\n",
            "*****************\n",
            "('pressor', 8088, 8095, 'ENTITY')\n",
            "*****************\n",
            "('urine cultures', 8104, 8118, 'ENTITY')\n",
            "*****************\n",
            "('positive', 8123, 8131, 'ENTITY')\n",
            "*****************\n",
            "('treated', 8145, 8152, 'ENTITY')\n",
            "*****************\n",
            "('vancomycin', 8153, 8163, 'ENTITY')\n",
            "*****************\n",
            "('ceftazidime', 8164, 8175, 'ENTITY')\n",
            "*****************\n",
            "('days', 8176, 8180, 'ENTITY')\n",
            "*****************\n",
            "('yeast', 8207, 8212, 'ENTITY')\n",
            "*****************\n",
            "('treated', 8213, 8220, 'ENTITY')\n",
            "*****************\n",
            "('right acetabulum', 8286, 8302, 'ENTITY')\n",
            "*****************\n",
            "('medial', 8352, 8358, 'ENTITY')\n",
            "*****************\n",
            "('osseous', 8416, 8423, 'ENTITY')\n",
            "*****************\n",
            "('right sacral ala iliac bone', 8496, 8523, 'ENTITY')\n",
            "*****************\n",
            "('patient pain', 8524, 8536, 'ENTITY')\n",
            "*****************\n",
            "('controlled', 8537, 8547, 'ENTITY')\n",
            "*****************\n",
            "('fentanyl lidocaine', 8548, 8566, 'ENTITY')\n",
            "*****************\n",
            "('bilateral', 8575, 8584, 'ENTITY')\n",
            "*****************\n",
            "('pleural effusion', 8585, 8601, 'ENTITY')\n",
            "*****************\n",
            "('agressive', 8621, 8630, 'ENTITY')\n",
            "*****************\n",
            "('sepsis hypoalbuminemia', 8649, 8671, 'ENTITY')\n",
            "*****************\n",
            "('effect significant', 8682, 8700, 'ENTITY')\n",
            "*****************\n",
            "('micu', 8709, 8713, 'ENTITY')\n",
            "*****************\n",
            "('development', 8714, 8725, 'ENTITY')\n",
            "*****************\n",
            "('hypotension', 8726, 8737, 'ENTITY')\n",
            "*****************\n",
            "('furosemide', 8747, 8757, 'ENTITY')\n",
            "*****************\n",
            "('improved', 8775, 8783, 'ENTITY')\n",
            "*****************\n",
            "('unchanged', 8798, 8807, 'ENTITY')\n",
            "*****************\n",
            "('nodular sclerosing hodgkin lymphoma', 8817, 8852, 'ENTITY')\n",
            "*****************\n",
            "('oncology interventions', 8858, 8880, 'ENTITY')\n",
            "*****************\n",
            "('bone marrow', 8893, 8904, 'ENTITY')\n",
            "*****************\n",
            "('anemia thrombocytopenia', 8926, 8949, 'ENTITY')\n",
            "*****************\n",
            "('hemolysis', 8978, 8987, 'ENTITY')\n",
            "*****************\n",
            "('treatment', 8988, 8997, 'ENTITY')\n",
            "*****************\n",
            "('oncology coagulopathy', 8998, 9019, 'ENTITY')\n",
            "*****************\n",
            "('mild', 9020, 9024, 'ENTITY')\n",
            "*****************\n",
            "('nutritional deficiency', 9032, 9054, 'ENTITY')\n",
            "*****************\n",
            "('po', 9065, 9067, 'ENTITY')\n",
            "*****************\n",
            "('intake', 9068, 9074, 'ENTITY')\n",
            "*****************\n",
            "('trend lfts', 9075, 9085, 'ENTITY')\n",
            "*****************\n",
            "('coags medications', 9086, 9103, 'ENTITY')\n",
            "*****************\n",
            "('admission', 9104, 9113, 'ENTITY')\n",
            "*****************\n",
            "('medications', 9114, 9125, 'ENTITY')\n",
            "*****************\n",
            "('admission', 9126, 9135, 'ENTITY')\n",
            "*****************\n",
            "('levothyroxine', 9138, 9151, 'ENTITY')\n",
            "*****************\n",
            "('daily', 9159, 9164, 'ENTITY')\n",
            "*****************\n",
            "('docusate sodium', 9167, 9182, 'ENTITY')\n",
            "*****************\n",
            "('omeprazole', 9192, 9202, 'ENTITY')\n",
            "*****************\n",
            "('ferrous sulfate', 9232, 9247, 'ENTITY')\n",
            "*****************\n",
            "('daily', 9255, 9260, 'ENTITY')\n",
            "*****************\n",
            "('qid', 9275, 9278, 'ENTITY')\n",
            "*****************\n",
            "('ultram', 9285, 9291, 'ENTITY')\n",
            "*****************\n",
            "('lasix', 9310, 9315, 'ENTITY')\n",
            "*****************\n",
            "('senna', 9330, 9335, 'ENTITY')\n",
            "*****************\n",
            "('aspirin', 9346, 9353, 'ENTITY')\n",
            "*****************\n",
            "('potassium chloride', 9369, 9387, 'ENTITY')\n",
            "*****************\n",
            "('multivitamin medications', 9391, 9415, 'ENTITY')\n",
            "*****************\n",
            "('acetaminophen', 9427, 9440, 'ENTITY')\n",
            "*****************\n",
            "('affected', 9498, 9506, 'ENTITY')\n",
            "*****************\n",
            "('folic acid 1', 9514, 9526, 'ENTITY')\n",
            "*****************\n",
            "('cap po daily 5', 9557, 9571, 'ENTITY')\n",
            "*****************\n",
            "('ipratropium bromide', 9572, 9591, 'ENTITY')\n",
            "*****************\n",
            "('neb 1 neb', 9592, 9601, 'ENTITY')\n",
            "*****************\n",
            "('bisacodyl', 9607, 9616, 'ENTITY')\n",
            "*****************\n",
            "('daily', 9623, 9628, 'ENTITY')\n",
            "*****************\n",
            "('tab', 9643, 9646, 'ENTITY')\n",
            "*****************\n",
            "('bid constipation', 9650, 9666, 'ENTITY')\n",
            "*****************\n",
            "('docusate sodium', 9669, 9684, 'ENTITY')\n",
            "*****************\n",
            "('bid', 9695, 9698, 'ENTITY')\n",
            "*****************\n",
            "('albuterol', 9701, 9710, 'ENTITY')\n",
            "*****************\n",
            "('neb soln', 9711, 9719, 'ENTITY')\n",
            "*****************\n",
            "('neb', 9722, 9725, 'ENTITY')\n",
            "*****************\n",
            "('metronidazole', 9736, 9749, 'ENTITY')\n",
            "*****************\n",
            "('flagyl', 9750, 9756, 'ENTITY')\n",
            "*****************\n",
            "('fentanyl', 9770, 9778, 'ENTITY')\n",
            "*****************\n",
            "('lidocaine', 9794, 9803, 'ENTITY')\n",
            "*****************\n",
            "('patch', 9806, 9811, 'ENTITY')\n",
            "*****************\n",
            "('ptch', 9814, 9818, 'ENTITY')\n",
            "*****************\n",
            "('right hip day', 9831, 9844, 'ENTITY')\n",
            "*****************\n",
            "('sarna lotion 1 appl', 9864, 9883, 'ENTITY')\n",
            "*****************\n",
            "('levothyroxine sodium', 9898, 9918, 'ENTITY')\n",
            "*****************\n",
            "('pantoprazole', 9935, 9947, 'ENTITY')\n",
            "*****************\n",
            "('iv discharge', 9954, 9966, 'ENTITY')\n",
            "*****************\n",
            "('medications', 9967, 9978, 'ENTITY')\n",
            "*****************\n",
            "('patient', 9979, 9986, 'ENTITY')\n",
            "*****************\n",
            "('discharge disposition', 10004, 10025, 'ENTITY')\n",
            "*****************\n",
            "('care discharge', 10035, 10049, 'ENTITY')\n",
            "*****************\n",
            "('urosepsis', 10060, 10069, 'ENTITY')\n",
            "*****************\n",
            "('aspiration pneumonitis', 10070, 10092, 'ENTITY')\n",
            "*****************\n",
            "('atrial fibrillation rvr lymphoma', 10093, 10125, 'ENTITY')\n",
            "*****************\n",
            "('condition', 10136, 10145, 'ENTITY')\n",
            "*****************\n",
            "('patient', 10146, 10153, 'ENTITY')\n",
            "*****************\n",
            "('discharge instructions', 10171, 10193, 'ENTITY')\n",
            "*****************\n",
            "('patient', 10194, 10201, 'ENTITY')\n",
            "*****************\n",
            "('followup', 10219, 10227, 'ENTITY')\n",
            "*****************\n",
            "('instructions', 10228, 10240, 'ENTITY')\n",
            "*****************\n",
            "('patient', 10241, 10248, 'ENTITY')\n",
            "*****************\n",
            "('initials', 10266, 10274, 'ENTITY')\n",
            "*****************\n"
          ]
        }
      ],
      "source": [
        "# Load a biomedical NLP model\n",
        "scispacy_nlp = load_nlp_model(\"en_core_sci_md\")\n",
        "\n",
        "# Preprocess text for Ecoli infection discharge summaries using scispacy\n",
        "ecoli_df['SCISPACY_PROCESSED_TEXT'] = ecoli_df['TEXT'].apply(lambda text: tokenize_text(text, \"en_core_sci_md\"))\n",
        "\n",
        "# Use scispacy to extract entities from the first discharge summary\n",
        "entities = extract_entities(ecoli_df.iloc[0]['SCISPACY_PROCESSED_TEXT'], \"en_core_sci_md\")\n",
        "\n",
        "# Print entities\n",
        "for entity in entities:\n",
        "    print(entity)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "aZkoI7JVVJGN",
        "outputId": "e069e71b-04a9-4ca2-b8c7-e9b1c0686d67"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " date 2194 1 7 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    discharge\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " date 2194 2 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    service medicine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " allergies \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " recorded having known \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    allergies drugs\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 290 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    chief complaint\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " altered \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mental status\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " major \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    surgical invasive procedure history\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " present \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    illness age\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 90 f \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    refractory\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " nodular sclerosing \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hodgkins lymphoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " brought \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ems\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " admitted home health care aide noted \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotensive\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " confused ed t rectal hr 101 bp rr 20 98 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    incontinant\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    stool\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 4 l ns \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    vanco\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 g iv ceftazadime 1 g iv flagyl 500 mg iv received mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ativan\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 2 mg iv \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    morphine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    agitation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pt \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admitted hospital unit\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 153 completed \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    course\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ceftazadime\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    vancomycin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    urosepsis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    course\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    metronidazole\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " completed \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    empiric treatment\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " diff given \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    loose stools\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " setting \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    elevated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    wbc count diff assays\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    negative\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pt \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    stabilized\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    transferred floor\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " care \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    time transfer\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    active issues\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " poor \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    nutritional status thrombocytopenia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    anemia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    floor\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pt experienced \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    episode\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " new \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    afib rvr\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " sbp 90 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    respiratory distress\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " received \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    fluid resuscitation concern syndrome\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pauses\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 4 sec telemetry ep curbside felt \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    digoxin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " recommended pt \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    readmitted\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " started \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    vancomycin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sites\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " possible \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    infection\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    erosions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    breasts right\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " hip question pna 2 rising wbc reaching high nearly 17 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    course\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " marked 1 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " responded gentle ns boluses 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    low\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " uop believed 2 22 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypovolemia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " low \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    baseline\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    nitrogenous urine output\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 3 recurrent afib transitioned \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    amiodarone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 400 mg po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " run 7 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    days\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " titrating \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    downward\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " past \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medical history\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    nodular sclerosing\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hodgkins lymphoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " inguinal \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lymphadenopathy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    local radiotherapy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " initially good results 8 23 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    progression\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    cytoxan\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " velban \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prednisone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " good response mass sacrum \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    radiation therapy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " severe \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypoxemia somnolence generalized edema anasarca\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " responsive diuresis oxygen supplements \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    discharged constant\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " oxygen cvvp \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    trial\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " stopped 10 28 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    low blood counts\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " modified regimen \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    chlorambucil\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 4 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    days\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 27 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    procarbazine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 50 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    days\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 27 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    velban\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 10 mg iv day 1 neulasta 6 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    day\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 8 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    chemotherapy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " discontinued given \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    poor response\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " l \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sided chest\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pain \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lytic lesions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " thoracic vertebrae received \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    radiation therapy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " including \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    right rib interval\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    decrease\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    vertebral lesions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lower extremity cellulitis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    gerd arthritis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    chronic ble edema hypothyroidism\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " hypertension \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    constipation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    social history\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " lives \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    home health care\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " aide \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    son ni\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " involved \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    care children\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " tobacco \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    alcohol illicit drug\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " use \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    family history\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    noncontributory\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    physical exam\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " initial \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    physical exam\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " general \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    elderly\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    female\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " acute distress \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    minimally reponsive verbal stimuli\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " responsive \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tactile\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    stimulation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " vitals t rectal hr 79 bp rr 15 sat nc heent sclera anicteric \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    moist\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mucous membranes\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " neck 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    carotid pulses\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " jvp elevation chest \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lungs\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " clear anteriorly laterally axillary lad heart regular murmurs \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    abd soft\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " non distended quiet bowel sounds \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    non tender percussion ext pitting edema feet bilaterally nonpalpable\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pulses feet cool reasonable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    capillary refill bilaterally neuro\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " sleepy arousable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pupils\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 2 mm \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilaterally\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " withdraws \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    painful\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " stimuli good strength \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    increased\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tone mute\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " reflexes \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilaterally toes\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " mute bilaterally \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    physical exam\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    time transfer\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " medical floor vitals t p 96 r 24 94 nc general \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    elderly\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    female\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " acute distress \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    minimally reponsive verbal stimuli\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " arousable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tactile\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " stimulation heent sclera anicteric \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    dry mucous membranes\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " neck 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    carotid pulses\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " lad \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    jvp\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " elevation chest diminished \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    breath sounds bases\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilaterally\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " axillary lad heart regular murmurs \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    abd soft distended\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    active bowel sounds\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    non tender percussion ext pitting edema extremities\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilaterally nonpalpable\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pulses feet cool reasonable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    capillary refill bilaterally neuro\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " sleepy arousable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pupils 3 4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " mm \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilaterally\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " withdraws \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    painful\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    stimuli\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " diminished \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    reflexes bilaterally physical exam transfer\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " vs \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    temp bp\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " hr 102 rr 31 94 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lnc\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    gen pleasant comfortable nad\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " somewhat \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    somnolent\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " falling asleep exam \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    heent\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " perrl \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    eomi\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    anicteric tachy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " mm op \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lesions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neck supraclavicular cervical lymphadenopathy jvd resp occ crackle bases\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " difficult assess \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    cooperative exam\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " cv rr abd nd soft nt masses hepatosplenomegaly ext warm anasarca \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    involvement\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    upper limbs\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    skin rashes\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    jaundice neuro\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " somewhat \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    somnolent\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " cn grossly intact difficult complete \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neuro\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " exam given \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    somnolence pertinent results\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 8 cxr impression persistent effusion definite \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    consolidation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    routine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pa lateral\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    films\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " recommended \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    evaluation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " feasible 1 10 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    echo left atrium\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " normal size \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    atrial septal defect\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " seen \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    color\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    doppler left ventricular wall\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " thicknesses normal \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left ventricular cavity\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " size normal overall \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left ventricular systolic function\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " normal right ventricular chamber size \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    free wall motion normal\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " aortic \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    valve leaflets\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " probably 3 mildly thickened aortic valve stenosis \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    trace aortic regurgitation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " seen \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mitral valve leaflets\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " mildly thickened \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    physiologic\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mitral regurgitation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " seen normal limits moderate \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pulmonary artery\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " systolic hypertension \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pericardial effusion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " based 2193 aha \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    endocarditis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prophylaxis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    recommendations\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    echo findings\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " indicate \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prophylaxis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " recommended \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    clinical decisions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " need \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prophylaxis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " based \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    clinical\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    echocardiographic\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    data\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " compared report prior \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    study images\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " unavailable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    review\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 2190 12 22 definite change brief \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hospital course\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    age\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 90 f \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    nodular sclerosing hodgkin lymphoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " initially admitted \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    urosepsis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " transferred \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    icu hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " afib rvr \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    goals care\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    long hospital course\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    family meetings reagarding\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    goals care\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 2194 1 21 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " family continued want \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    icu transfers\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pressors\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " needed regardless \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    comfort\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " tranferred unit 2194 1 30 started \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    levophed hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " eventually \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    decision medically futile\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    escalate care care\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " escalated expired 2194 2 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    family\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " declined \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    autopsy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    afib\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " rvr pt experienced \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    transient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " episodes afib 150 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    controlled\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    diltiazem\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    metoprolol\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    spontaneous\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    conversion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " multiple episodes 4 second \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pauses\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bradycardia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 40 likely \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    junctional escape\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    digoxin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " considered unfavorable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pt started \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    amiodarone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    gtt\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " converted \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    amiodarone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient readmitted\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " icu 2194 1 30 having \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    increased\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pauses\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 20 seconds \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    amiodarone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " stopped \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    anemia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    thrombocytopenic admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " thought \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    secondary marrow infiltration lymphoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    transfused\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " total 3 units \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    plt 1 unit\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 14 1 19 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    transfusion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    threshold\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 10 continue \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    trend\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    platelets\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    transfuse bleeding\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    platelet count\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 10 transfused 1 unit \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    platelets\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " good bump 1 25 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " receiving \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prbc transfusions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " hct 24 total units 2194 1 12 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " early admission having \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotensive episodes\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    furosemide\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    responsive\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    fluid\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    blosues\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 250 cc \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    echo\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " demonstrated \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    impaired\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lv relaxation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " given \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    elevated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " wbc concern distributive shock longer fluid responsive started \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    phenylephrine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    gtt\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    weaned hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " later \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " thought \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    secondary\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    systemic vasodilation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " started \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    levophed decision escalate care infection\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " wbc \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    elevated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " multiple possible \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    infectious\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sources\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " contribute \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " ie \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    skin erosions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    breasts\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " course \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    breath sounds pna vanc\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    piptaz\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " started 1 22 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    cultures\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    blood urine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pending \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sputum\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " obtainable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    point cdiff\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " repeated toxin c diff neg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    flagyl 1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 24 gnr \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    skin swab hypernatremia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " noted periodically \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypernatremic admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " na 148 150 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    free water\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " defecit getting slow infusions poor po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intake\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " able \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    free water\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " intake altered \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mental status\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    increased\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lethargy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " compared \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    baseline admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " likely 2 22 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    metabolic encephalopathy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " infection acute renal failure slight improvement resolution urosepsis head ct negative acute process thyroid studies elevated tsh sick euthyroid syndrome \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    respiratory distress\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " early \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " developed \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    labored breathing\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " receiving 1 l \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ns hypotension flash pulmonary edema diuresis furosemide\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    gtt lead hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " albumin \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    resuscitation lead\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " repeated \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    respiratory distress\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 2194 1 30 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    floor\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " witnessed aspiration \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    event\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " needed 100 hi \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    flow mask icu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    weaned\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " aspirated \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    increasing\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    requirements\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    acute renal failure\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pt noted \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    cr admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " presumed \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    baseline\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " returned \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    baseline\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " likely \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    dehydration hypotension sepsis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " later \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hospital course\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotensive creatinine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " began rise thought \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    secondary atn hypothyroidism\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " initially \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    levothyroxine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " mcg iv daily half home dose low tsh \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    elevated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " resumed \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    home dose\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    anasarca\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pt diffuse \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    edema\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " large \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilateral\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pleural effusions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " likely \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    malnutrition\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " given \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    low albumin admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " poor po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intake\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    diuresis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    difficult\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " detailed continue monitor \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    urosepsis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admitted\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotension urosepsis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " requiring \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pressor\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " support \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    urine cultures\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 9 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    positive\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pt completed \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    vancomycin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ceftazidime\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    days\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " repeat ucx 2194 1 19 grew \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    yeast\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " repeat ucx 1 22 final grew yeast right hip pain pain destruction \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    right acetabulum\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " consistent progressive lymphoma ct scan dramatic \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medial\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " displacement right femoral head secondary lack remaining \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    osseous\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " support stable destruction right posterior sacroiliac joint surrounding \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    right sacral ala iliac bone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient pain\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    controlled\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    fentanyl lidocaine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " patches \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilateral\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pleural effusion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " r l thought likely \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    agressive\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " hydration setting \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sepsis hypoalbuminemia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " difficult \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    effect significant\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " diurese \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    micu\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    development\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypotension\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " response \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    furosemide\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " appears slightly \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    improved\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " cxr 2194 1 17 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    unchanged\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 20 cxr \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    nodular sclerosing hodgkin lymphoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " seen \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    oncology interventions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " time likely \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bone marrow\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " infiltration causing \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    anemia thrombocytopenia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " pt low retic count evidence \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hemolysis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treatment\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    oncology coagulopathy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mild\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " likely \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    nutritional deficiency\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " encourage \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    po\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intake\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    trend lfts\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    coags medications\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medications\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    levothyroxine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 25 mcg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    docusate sodium\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 100 mg 3 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    omeprazole\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 20 mg daily 4 5 325 mg prn 5 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ferrous sulfate\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 325 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 6 3 300 30 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    qid\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " prn 7 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ultram\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 50 mg 4 6 hours 8 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lasix\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 20 mg daily 9 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    senna\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " mg prn 10 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    aspirin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 81 mg daily 11 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    potassium chloride\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 12 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    multivitamin medications\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " transfer 1 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    acetaminophen\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 325 650 mg prn 2 miconazole powder 2 1 appl tp tid apply \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    affected\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " area 3 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    folic acid 1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " mg po daily 4 multivitamins 1 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    cap po daily 5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ipratropium bromide\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neb 1 neb\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " ih 6 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bisacodyl\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 10 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " prn 7 senna 1 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tab\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bid constipation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 8 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    docusate sodium\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 100 mg po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bid\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 9 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    albuterol\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neb soln\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neb\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " ih prn 10 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    metronidazole\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    flagyl\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 500 mg iv 11 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    fentanyl\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " patch 25 tp 12 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lidocaine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 5 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patch\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ptch\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " td qd apply \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    right hip day\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 12 hours remove 13 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sarna lotion 1 appl\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " tp tid prn 14 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    levothyroxine sodium\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " mcg iv daily 15 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pantoprazole\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 40 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    iv discharge\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medications\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " expired 2194 2 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    discharge disposition\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " extended \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    care discharge\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " diagnosis \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    urosepsis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    aspiration pneumonitis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    atrial fibrillation rvr lymphoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " discharge \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    condition\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " expired 2194 2 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    discharge instructions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " expired 2194 2 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    followup\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    instructions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " expired 2194 2 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    initials\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " md md md 292</div></span>"
            ],
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "*********************************************************************************************************************************************************************\n"
          ]
        }
      ],
      "source": [
        "# Visualize entities in the first discharge summary PROCESSED_TEXT\n",
        "doc = scispacy_nlp(ecoli_df['SCISPACY_PROCESSED_TEXT'].iloc[0])\n",
        "displacy.render(doc, style=\"ent\", jupyter=True)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Corpus & Word Vectors"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "3onlw3ecxqn-",
        "outputId": "cdb6675b-0e63-4473-cc00-bf9aa2e4bdab"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "strep_df has data\n",
            "Processing row 0: admission date 2194 1 7 discharge date 2194 2 2 service medicine allergies patient recorded having known allergies drugs 290 chief complaint altered mental status hypotension major surgical invasive procedure history present illness age 90 f refractory nodular sclerosing hodgkins lymphoma brought ems admitted home health care aide noted hypotensive confused ed t rectal hr 101 bp rr 20 98 incontinant stool treated 4 l ns vanco 1 g iv ceftazadime 1 g iv flagyl 500 mg iv received mg ativan 2 mg iv morphine agitation pt admitted hospital unit 153 completed course ceftazadime vancomycin urosepsis course metronidazole completed empiric treatment diff given loose stools setting elevated wbc count diff assays negative pt stabilized transferred floor care time transfer active issues poor nutritional status thrombocytopenia anemia floor pt experienced episode new afib rvr hypotension sbp 90 respiratory distress received fluid resuscitation concern syndrome pauses 4 sec telemetry ep curbside felt digoxin recommended pt readmitted micu micu started vancomycin 1 sites possible infection erosions breasts right hip question pna 2 rising wbc reaching high nearly 17 micu course marked 1 hypotension responded gentle ns boluses 2 low uop believed 2 22 hypovolemia low baseline nitrogenous urine output 3 recurrent afib transitioned amiodarone 400 mg po daily run 7 days titrating downward past medical history nodular sclerosing hodgkins lymphoma inguinal lymphadenopathy treated local radiotherapy initially good results 8 23 progression treated cytoxan velban prednisone good response mass sacrum treated radiation therapy severe hypoxemia somnolence generalized edema anasarca responsive diuresis oxygen supplements discharged constant oxygen cvvp trial stopped 10 28 low blood counts modified regimen chlorambucil 4 mg daily days 1 27 procarbazine 50 mg daily days 1 27 velban 10 mg iv day 1 neulasta 6 mg day 8 chemotherapy discontinued given poor response l sided chest pain lytic lesions thoracic vertebrae received radiation therapy including right rib interval decrease vertebral lesions lower extremity cellulitis gerd arthritis chronic ble edema hypothyroidism hypertension constipation social history lives home health care aide son ni involved care children tobacco alcohol illicit drug use family history noncontributory physical exam initial physical exam general elderly female acute distress minimally reponsive verbal stimuli responsive tactile stimulation vitals t rectal hr 79 bp rr 15 sat nc heent sclera anicteric moist mucous membranes neck 2 carotid pulses jvp elevation chest lungs clear anteriorly laterally axillary lad heart regular murmurs abd soft non distended quiet bowel sounds non tender percussion ext pitting edema feet bilaterally nonpalpable pulses feet cool reasonable capillary refill bilaterally neuro sleepy arousable pupils 1 2 mm bilaterally withdraws painful stimuli good strength increased tone mute reflexes bilaterally toes mute bilaterally physical exam time transfer medical floor vitals t p 96 r 24 94 nc general elderly female acute distress minimally reponsive verbal stimuli arousable tactile stimulation heent sclera anicteric dry mucous membranes neck 2 carotid pulses lad jvp elevation chest diminished breath sounds bases bilaterally axillary lad heart regular murmurs abd soft distended active bowel sounds non tender percussion ext pitting edema extremities bilaterally nonpalpable pulses feet cool reasonable capillary refill bilaterally neuro sleepy arousable pupils 3 4 mm bilaterally withdraws painful stimuli diminished reflexes bilaterally physical exam transfer micu vs temp bp hr 102 rr 31 94 2 lnc gen pleasant comfortable nad somewhat somnolent falling asleep exam heent perrl eomi anicteric tachy mm op lesions neck supraclavicular cervical lymphadenopathy jvd resp occ crackle bases difficult assess patient cooperative exam cv rr abd nd soft nt masses hepatosplenomegaly ext warm anasarca involvement upper limbs skin rashes jaundice neuro somewhat somnolent cn grossly intact difficult complete neuro exam given somnolence pertinent results 1 8 cxr impression persistent effusion definite consolidation routine pa lateral films recommended evaluation feasible 1 10 echo left atrium normal size atrial septal defect seen color doppler left ventricular wall thicknesses normal left ventricular cavity size normal overall left ventricular systolic function normal right ventricular chamber size free wall motion normal aortic valve leaflets probably 3 mildly thickened aortic valve stenosis trace aortic regurgitation seen mitral valve leaflets mildly thickened physiologic mitral regurgitation seen normal limits moderate pulmonary artery systolic hypertension pericardial effusion based 2193 aha endocarditis prophylaxis recommendations echo findings indicate prophylaxis recommended clinical decisions need prophylaxis based clinical echocardiographic data compared report prior study images unavailable review 2190 12 22 definite change brief hospital course age 90 f nodular sclerosing hodgkin lymphoma initially admitted urosepsis transferred icu hypotension afib rvr goals care patient long hospital course family meetings reagarding goals care 2194 1 21 patient family continued want icu transfers pressors needed regardless comfort patient patient tranferred unit 2194 1 30 started levophed hypotension eventually decision medically futile escalate care care escalated expired 2194 2 2 family declined autopsy afib rvr pt experienced transient episodes afib 150 controlled diltiazem metoprolol spontaneous conversion multiple episodes 4 second pauses bradycardia 40 likely junctional escape digoxin considered unfavorable patient micu pt started amiodarone gtt converted amiodarone po patient readmitted icu 2194 1 30 having increased pauses 20 seconds amiodarone stopped patient anemia thrombocytopenic admission thought secondary marrow infiltration lymphoma transfused total 3 units plt 1 unit 1 14 1 19 transfusion threshold 10 continue trend platelets transfuse bleeding platelet count 10 transfused 1 unit platelets good bump 1 25 patient receiving prbc transfusions hct 24 total units 2194 1 12 hypotension early admission having hypotensive episodes furosemide responsive fluid blosues 250 cc echo demonstrated impaired lv relaxation given elevated wbc concern distributive shock longer fluid responsive started phenylephrine gtt weaned hypotension later admission thought secondary systemic vasodilation started levophed decision escalate care infection wbc elevated multiple possible infectious sources contribute hypotension ie skin erosions breasts course breath sounds pna vanc piptaz started 1 22 cultures blood urine pending sputum obtainable point cdiff repeated toxin c diff neg flagyl 1 24 gnr skin swab hypernatremia noted periodically hypernatremic admission na 148 150 free water defecit getting slow infusions poor po intake able free water intake altered mental status increased lethargy compared baseline admission likely 2 22 metabolic encephalopathy infection acute renal failure slight improvement resolution urosepsis head ct negative acute process thyroid studies elevated tsh sick euthyroid syndrome respiratory distress early admission patient developed labored breathing receiving 1 l ns hypotension flash pulmonary edema diuresis furosemide gtt lead hypotension albumin resuscitation lead repeated respiratory distress 2194 1 30 floor witnessed aspiration event needed 100 hi flow mask icu weaned aspirated increasing requirements acute renal failure pt noted cr admission presumed baseline returned baseline likely dehydration hypotension sepsis later hospital course patient hypotensive creatinine began rise thought secondary atn hypothyroidism initially treated levothyroxine mcg iv daily half home dose low tsh elevated resumed home dose anasarca pt diffuse edema large bilateral pleural effusions likely malnutrition given low albumin admission poor po intake diuresis difficult hypotension detailed continue monitor urosepsis admitted hypotension urosepsis requiring pressor support urine cultures 1 9 positive pt completed treated vancomycin ceftazidime days repeat ucx 2194 1 19 grew yeast treated repeat ucx 1 22 final grew yeast right hip pain pain destruction right acetabulum consistent progressive lymphoma ct scan dramatic medial displacement right femoral head secondary lack remaining osseous support stable destruction right posterior sacroiliac joint surrounding right sacral ala iliac bone patient pain controlled fentanyl lidocaine patches bilateral pleural effusion r l thought likely agressive hydration setting sepsis hypoalbuminemia difficult effect significant diurese micu development hypotension response furosemide appears slightly improved cxr 2194 1 17 unchanged 1 20 cxr nodular sclerosing hodgkin lymphoma seen oncology interventions time likely bone marrow infiltration causing anemia thrombocytopenia pt low retic count evidence hemolysis treatment oncology coagulopathy mild likely nutritional deficiency encourage po intake trend lfts coags medications admission medications admission 1 levothyroxine 25 mcg daily 2 docusate sodium 100 mg 3 omeprazole 20 mg daily 4 5 325 mg prn 5 ferrous sulfate 325 mg daily 6 3 300 30 mg qid prn 7 ultram 50 mg 4 6 hours 8 lasix 20 mg daily 9 senna mg prn 10 aspirin 81 mg daily 11 potassium chloride 12 multivitamin medications transfer 1 acetaminophen 325 650 mg prn 2 miconazole powder 2 1 appl tp tid apply affected area 3 folic acid 1 mg po daily 4 multivitamins 1 cap po daily 5 ipratropium bromide neb 1 neb ih 6 bisacodyl 10 mg daily prn 7 senna 1 tab po bid constipation 8 docusate sodium 100 mg po bid 9 albuterol neb soln 1 neb ih prn 10 metronidazole flagyl 500 mg iv 11 fentanyl patch 25 tp 12 lidocaine 5 patch 1 ptch td qd apply right hip day 12 hours remove 13 sarna lotion 1 appl tp tid prn 14 levothyroxine sodium mcg iv daily 15 pantoprazole 40 mg iv discharge medications patient expired 2194 2 2 discharge disposition extended care discharge diagnosis urosepsis aspiration pneumonitis atrial fibrillation rvr lymphoma discharge condition patient expired 2194 2 2 discharge instructions patient expired 2194 2 2 followup instructions patient expired 2194 2 2 initials md md md 292\n",
            "Processing row 1: admission date 2200 10 21 discharge date 2200 10 27 date birth 2139 8 15 sex f service medicine allergies iron dextran complex lf 832 chief complaint respiratory failure major surgical invasive procedure bronchoscopy intubation hemodialysis hd line placement history present illness 61 female esrd hd stage iv nslc lung cancer egfr wild type htn presents respiratory distress patient cough feeling went dialysis coughing intensely point needles came av graft appeared short breath unclear ems course presentation ed eyes open verbal history obtained cousin ni note lung cancer involves right upper lobe mass adjacent nodes patient met stitle month started vinorelbin palliative chemotherapy 2 weeks ago addition patient admit weight 62 kg estimated dry weight 58 kg ed course initial vs 10 21 t hr 100 bp rr 32 sat 84 triggered respiratory distress eyes open question status ed physician spoke doctor titles 732 stated want intubated intubated ett ricironium 60 mg etomidate 20 mg sedation versed propofol intubation vs 95 25 99 vent cxr revealed rul opacity given ceftriaxone 1 gm iv x 1 levofloxacin 750 mg iv x 1 initially followed addition vancomycin 1 gm iv x 1 cover hcap ekg showing sinus tach twi 6 peaked t floor patient sedation tolerating ventilator renal consulted hd noticed left graft functioning placed rij line dialysis access dialysis going performed hypotensive maps high cvp 4 propofol switched dialysis performed patient subsequently underwent bronchoscopy bal showing rl apical segmental occlusion tumor 90 anterior segment occlusion patent posterior segment pressure subsequently review systems patient unable answer past medical history poorly differentiated w believed lymphangitic spread cell renal carcinoma r nephrectomy type 2 retinopathy neuropathy airway disease likely copd poorly controlled hypertensive urgency recent cr values 4 anemia thought 12 24 ckd tte 2200 1 2 lvef 30 moderate mr moderate pulmonary artery hypertension lower pain mass followed biopsy social history lives roomate un 813 apt grew family carnival worker traveled illiterate smokes 50 pack yr history ssi currently family support un 802 ny family history multiple family members dm mi cva uncle cousins kidney disease requiring dialysis mother breast cancer physical exam vitals t hr 94 bp rr 25 99 cmv 50 peep 8 pip 28 vt 500 vent settings tv 400 rr 20 peep 8 50 general intubated sedation heent sclera anicteric mmm oropharynx clear neck supple jvp elevated lad lungs clear auscultation bilaterally wheezes rales ronchi cv regular rate rhythm normal murmurs rubs gallops port test abdomen soft bowel sounds present rebound tenderness guarding organomegaly gu foley ext warm perfused ue le cool 2 pulses clubbing cyanosis edema left arm graft bruit thrill rij place pertinent results admission labs 2200 10 21 blood plt 2200 10 21 blood 2200 10 21 blood tear stitle 833 2200 10 21 blood 2200 10 21 blood 23 2200 10 21 blood 2200 10 21 blood 2200 10 21 blood 2200 10 21 blood un 2200 10 21 blood tidal 100 91 69 26 base 584 req 92 2200 10 21 blood 24 2200 10 21 blood 2200 10 21 blood cardiac enzymes 2200 10 21 blood 2200 10 21 blood 2200 10 22 blood 2200 10 22 blood bronchial washing 2200 10 21 negative malignant cells admission ekg 2200 10 21 sinus tachycardia intraventricular conduction delay left ventricular hypertrophy wave abnormalities intraventricular conduction delay left ventricular hypertrophy possible ischemia clinical correlation suggested previous tracing 2200 7 29 sinus tachycardia present wave abnormalities prominent chest x ray 2200 10 21 impression multiple limitations diffuse severe pulmonary edema dense consolidation right indicate confluent edema pneumonia underlying mass lesion excluded echo 2200 10 22 left atrium normal size mild symmetric left ventricular hypertrophy normal cavity size overall left ventricular systolic function moderately depressed xx right ventricular chamber size free wall motion normal aortic valve leaflets 3 mildly thickened aortic stenosis present trace aortic regurgitation seen mitral valve leaflets mildly thickened mitral valve prolapse physiologic mitral regurgitation seen normal limits tricuspid valve leaflets mildly thickened pulmonary artery systolic pressure determined pericardial effusion impression mild symmetric lvh moderate severe global hypokinesis lateral wall function relatively better significant mitral regurgitation seen chest x ray 2200 10 24 complete opacification right upper lung increase right mediastinal shift findings consistent interval development atelectasis potentially additional cause precludes significant volume loss hemorrhage correlation bronchoscopy highly recommended position tubes lines left perihilar region opacities unchanged brief hospital course assessment plan 61 female esrd hd stage iv nsclc involving rul htn presents acute respiratory distress rul opacification secondary possible pneumonia addition initial neutropenia respiratory distress known lastname 784 originally intubated ventilated icu setting admission initially failing pressure support trial ultimately able extubated 2200 10 23 discussion family concluded patient extubated initially failing trial pressure support cause respiratory distress thought likely multifactorial rul opacification representing pneumonia given bronchscopy pulmonary edema contribution clinically evident lymphangitic spread cancer goals care conversation family hcp decision reintubate ultimately cmo kept comfortable morphine concentrated oral solution scopolamine patch secretion control started morphine gtt bolus morphine breakthrough 12 24 tachypnea 2200 10 27 patient passed away 2200 10 27 sepsis secondary pneumonia subsequent coli bacteremia patient leukocytosis fever micu stay originally treated changed zosyn cx data returned admission neutropenic un 834 vinrelbin chemo 2 weeks pta resolved time source bacteremia thought likely 12 24 pulmonary system decision cmo antibiotics discontinued kept comfortable tylenol liquid prn fever mixed respiratory acidosis metabolic alkalosis metabolic acidosis resolved dialysis continued respiratory acidosis likely secondary hypoventilation abgs blood draws monitor lytes k discontinued patient cmo hypotension patient issues dependent hypotension micu course patient appeared adequately resuscitated recent echo showed moderate severe hypokinesis represent myocardial depression 12 24 sepsis acute illness baseline heart disease patient cmo dialysis discontinued vital signs longer taken ekg changes twi different prior admission state acute illness demand ischemia possible ekg changes resolved morning troponins bland acute plaque rupture unlikely cardiac medications stopped micu stay restarted given cmo status asa plavix lipitor heparin gtt chronic kidney disease requiring hd hd performed renal micu stay medications renally dosed nephrotoxins iv contrast avoided setting ckd hd discontinued patient cmo stage iv nsclc discussed primary oncologist stitle thinks chemotherapy unlikely provide patient benefit anemia baseline hgb 11 current stable 8 evidence acute blood loss trended patient cmo labs checked chronic heart failure systolic ef 30 mr stitle active signs heart failure transient diastolic function cause pulmonary edema echo showed resolving mr history reactive airway disease continued ipratropium nebs cmo status point family felt pt derive help diabetes pt receive oral hypoglycemics placed ssi stopped cmo goals care multiple family meetings held icu attending note details hcp ni 835 pressors given health deteriorated micu stay patient cmo family including hcp light pneumonia difficult treat setting stage iv nsclc transferred medicine floor lines vital sign checks lab draws discontinued family remained bedside patient prescribed medications comfort included tylenol liquid morphine sulfate concentrated oral solution ativan haldol note sw saw pt provided counseling family stay wardname 836 medications admission albuterol sulfate prescribed provider 90 mcg hfa aerosol inhaler 11 23 inhaled 4 hours needed shortness breath wheezing b acid nephrocaps prescribed provider 1 mg capsule 1 mouth daily calcium acetate prescribed provider 667 mg capsule 2 caps mouth 3 x daily furosemide lasix prescribed provider 40 mg tablet 1 mouth day gabapentin prescribed provider 100 mg capsule 2 mouth day hair prosthesis use scalp needed alopecia icd 9 lactulose 10 ml solution 15 ml mouth twice day constipation metoprolol succinate 50 mg tablet sustained release 24 hr 1 mouth day omeprazole prescribed provider 20 mg capsule delayed 1 mouth day oxycodone 20 mg tablet sustained release 12 hr 1 mouth twice day icd 9 oxycodone 5 mg tablet 1 mouth 8 hours needed pain breakthrough pain icd 9 prochlorperazine maleate 10 mg tablet 1 mouth 8 hours needed nausea nausea chemotherapy simvastatin 80 mg tablet 1 mouth day tiotropium bromide spiriva handihaler 18 mcg capsule device 1 ih ih daily medications otc aspirin prescribed provider 81 mg tablet 1 mouth day docusate sodium prescribed provider 100 mg capsule 12 mouth 2 x daily needed asneeded discharge medications discharge disposition expired discharge diagnosis post obstructive pna setting stage iv nsclc discharge condition expired discharge instructions followup instructions completed 10 28\n",
            "Processing row 2: admission date 2163 7 5 discharge date 2163 7 15 date birth 2097 6 11 sex f service medicine allergies bactrim ciprofloxacin codeine lf 1162 chief complaint ams major surgical invasive procedure history present illness 66 yo f pe renal failure cr 5 seizure found apparently days unwitnessed seizure pt managed crawl window yell help ems arrived took pt osh pt recently hospitalized malaise date range 1 found renal failure thought setting poor po intake hypotension adrenal insufficiency steriods cr improved ivf discharged cefuroxime uti abx completed 6 24 pt discharged extended care facility 6 17 osh arrived ems speech slurred found pt filthy appt dried feces legs cat feces urine feces initial vs bp hr 103 fs 73 initial k alb wbc hct plt 444 inr tox screen benzos opiates serum detected received cefuroxime 750 mg po solumedrol 125 mg iv linezolid 600 mg pt transferred 18 furhter management arf 18 ed course initial vs bp hr 94 18 sbp dropped received l ns ivf dropped 89 ra increased 96 nc noted rhabdo acute chronic renal failure aggressive fluid resuscitation started renal function improved ck trending ua noted equivocal uti grew vre id likely colonization noted gram positive cocci bacteremia started vancomycin speciation currently pending pt subsequently transferred floor management arrival specific complaint refusing vancomycin agrees medicationse pt ros denies cough chest pain palpitations abdominal dysuria confused ha visual changes poor historian paranoid tangential speech fully evaluate past medical history multiple pulmonary emboli anticoagulation utis vre uits linezolid disorder disease chronic steroids quiescent sulfasalazine nodules breast mass diagnosed 2154 disease hyperparathyroidism cholecystectomy total knee replacement oa r knee obesity social history lives cats found filthy apt feces apt apparently condemned sw involved pt refused vna elder services past able adls smoked patient difficult social situation vna public health department involved condemning house son daughter contacts family history physical exam pe vs bp hr rr 92 gen appears comfortable rest apparent distress heent perrl oropharynx clear tm clear neck supple jvd nodes cv rrr nl resp ctab nl effort abd distended soft non tender nl bs ext neuro self year cns 2 14 grossly intact pertinent results admit 2 2163 7 5 2163 7 5 2163 7 5 2163 7 5 plt plt 2163 7 5 2163 7 5 alk tot 2163 7 5 2163 7 5 cardiac 2163 7 5 2163 7 5 mb 2163 7 5 mb 2163 7 5 2163 7 6 blood 2163 7 7 blood 2163 7 5 blood mb 2163 7 6 blood anemia 2163 7 5 vit 1098 2163 7 5 discharge ct head 7 5 evidence intracranial hemorrhage mass effect shift midline structures hydrocephalus acute major vascular territorial infarct doctor differentiation appears preserved unchanged appearance age appropriate atrophy mild calcifications noted carotid siphons bilaterally soft tissues osseous structures appear unremarkable paranasal sinuses mastoid air cells aerated impression acute intracranial pathology ct 7 5 findings evidence acute fracture dislocation multilevel degenerative joint degenerative disc disease prevertebral soft tissue swelling identified visualized contents intrathecal sac appear unremarkable note overall examination slightly limited large artifact shoulders impression acute fracture dislocation 7 5 findings linear atelectasis noted left base lungs appear clear mild indistinctness perihilar vessels engorgement pulmonary vasculature suggest mild fluid overload patient known renal failure evidence pneumothorax cardiomediastinal silhouette hilar contours significantly changed large right effusion identified left costophrenic angle included current film surgical hardware right total shoulder replacement identified impression 1 evidence pneumonia left lower lobe linear atelectasis 2 perihilar haziness congestion pulmonary vasculature likely relates fluid overload patient known renal failure 7 5 ecg sinus rhythm 89 borderline degree block compared tracing 2163 6 14 premature atrial beats absent 7 8 echo conclusions limited images obtained suboptimal technical quality focal wall motion abnormality fully excluded left ventricular systolic function hyperdynamic pericardial effusion brief hospital course 66 yo f paranoid seizure ckd pe anticoagulation found 9 days noted acute chronic renal failure apparent gram positive cocci bacteremia patient admitted hospital unit 153 7 5 transferred floor 7 7 following issues addressed admission 1 change patient noted home etiology thought secondary seizure patient maintained tid klonopin seizure prophylaxis home patient head ct negative utox positive benzos opiates metabolic derangements evidence trauma acute process ct cardiac enzymes cycled remained flat ekg unchanged baseline patient mental status improved stay baseline discharge neurology consulted patient recommended initiation dilantin seizure management seizures stay initially klonopin 1 mg tid dilantin loaded 7 8 evening start daily dilantin dosing 600 mg qhs 7 9 7 10 patient started keppra recommended neuro dilantin discontinued difficult dosing given patient weight difficulty managing coumadin dosing dilantin interaction keppra titrated patient discharged dose 1000 mg po twice daily evidence seizure activity hospitalization 2 renal creatinine presentation acute chronic renal failure likely secondary dehydration evidence atn muddy brown casts peak ck 1400 making rhadbomyolysis likely patient recieved aggressive fluid resuscitation ed icu 24 48 hours continued require ivf 7 7 nephrology followed patient hospitalization renal failure improved rapidly time discharge creatinine massive diuresis lytes aggressivly repleted nsaids held stay sulfasalazine initially held 7 7 patient creatinine normalized hospitalization discharge 3 hypotension pt initial sbp responded fluids febrile received abx relative adrenal insufficiency hypotension steroids recent admission 2163 6 3 likely volume related relative adrenal insufficiency steroids po intake days resolved aggressive hydration home dose prednisone 5 mg crohn empiric vancomycin initiated date range 1 1164 discontinued time 4 id patient history vre utis past 7 10 began rising leukocytosis remained afebrile patient ua borderline uti time 5 wbc repeat performed following day subsequent culture grew gram negative rods later identified coli patient initially placed levofloxacin po sensitivities showed resistance switched iv ceftriaxone note prior ceftriaxone received dose unasyn levofloxacin patient developed spiking temperatures 101 ams tachycardia blood cultures obtained subsequently grew similar sensitivities id consult obtained recommended week course ceftriaxone iv daily total 14 days picc line placed day discharge ir antibiotic therapy 5 crohn sulfasalazine 7 7 diarrhea crohn symptoms maintained prednisone 5 mg daily history depression anxiety paranoia admission patient felt paranoid found filthy apartment admission refused services paranoia head ct negative psych evaluated started standing haldol haldol agitation continued clonopin 7 7 improvement mental status patient paranoia improved haldol discontinued doxapin restoril patient previous baseline patient deemed capacity decisions 7 pe anticoagulation inr admission coumadin initially held admission resumed coumadin outpatient dose 2 mg po daily need lovenox 40 mg sc daily therapeutic inr today goal 2 5 8 hypothyroidism tsh wnl continued levothyroxine daily 9 asthma maintained home regimen singulair prednisone crohn patient found ems filthy conditions multiple animals urine feces department public health involved trying clean house patient son ni deemed capacity return current living situation rehab housing cleaned code status communication pt hcp ni ni 1151 ni 1165 hcp 1 1152 friend ni 1 1153 niece ni 1154 ni 1155 1 1156 medications admission 1 levothyroxine 200 mcg qam 2 clonazepam 2 mg tid 3 methylphenidate 10 mg daily 4 citalopram 20 mg daily 5 montelukast 10 mg daily 6 doxepin 50 mg qhs 7 warfarin 2 mg daily 8 prednisone 5 mg daily adjust dose directed primary care physician 9 nabumetone 750 mg qhs 10 sulfasalazine 500 mg 11 cyclobenzaprine 10 mg daily 12 hydromorphone 4 mg prn discharge medications 1 levothyroxine 100 mcg tablet sig 2 tablet po daily daily 2 clonazepam 1 mg tablet sig 1 tablet po tid 3 times day 3 methylphenidate 10 mg tablet sig 1 tablet po daily daily 4 montelukast 10 mg tablet sig 1 tablet po daily daily 5 prednisone 5 mg tablet sig 1 tablet po daily daily 6 pantoprazole 40 mg tablet delayed release sig 1 tablet delayed release po 24 hours 7 sulfasalazine 500 mg tablet sig 1 tablet po bid 2 times day 8 doxepin 25 mg capsule sig 2 capsule po hs bedtime 9 temazepam 15 mg capsule sig 2 capsule po hs bedtime needed 10 acetaminophen 325 mg tablet sig 1 tablet po 6 hours needed pain fever 11 miconazole nitrate 2 powder sig 1 appl topical tid 3 times day needed 12 warfarin 2 mg tablet sig 1 tablet po hs bedtime 13 levetiracetam 500 mg tablet sig 2 tablet po twice day 14 docusate sodium 100 mg capsule sig 1 capsule po bid 2 times day 15 bisacodyl 5 mg tablet delayed release sig 2 tablet delayed release po daily daily needed 16 2 ml piggyback sig 1 intravenous 24 hours 13 days days 17 lovenox 40 ml syringe sig 1 subcutaneous day inr 2 coumadin discharge disposition extended care facility nursing center location un 1157 discharge diagnosis 1 urosepsis 2 acute renal failur 3 seizure secondary pulmonary ebmolism asthma crohn disease depression adrenal insufficiency discharge condition stable taking good po discharge instructions patient discharged rehab facility continue iv ceftriaxone weeks duration followup instructions follow primary care doctor follow gastroenterologist seizures follow neurology stitle 724 seen follow number 1 1166\n",
            "Processing row 3: admission date 2100 8 8 discharge date 2100 8 12 date birth 2015 2 6 sex m service year 4 digits 662 allergies procainamide lf 3853 chief complaint altered mental status hypotension major surgical invasive procedure history present illness 85 yo m pmh bladder cad htn transferred osh concern urosepsis pt presented osh day prior admission shaking chills altered mental status pt reports urinary incontinece past days abnormal denies dysuria reports awaking middle night shaking chills recall happed girlfriend taken ni arrival osh febrile given 1 dose tylenol ua osh positive uti bp dropped given 3 fluids improvement bp head ct concern altered mental status setting anticoagulation report negative transferred care given providers arrival 18 ed febrile rectally given 650 mg tylenol initially hemodyanmially stable bp drop transiently given bolus fluid good response bp stable prior transfer floor repeat blood urine cultures performed admitted possible urosepsis arrival micu patient sleepy complains chronic left sided pain denies recent suprapubic pain nausea vomiting flank pain uti 2091 denies hematuria changes urine color 10 point ros negative past medical history bladder followed stitle 3854 recent urine cytology cystoscopy showed clusters highly atypical urothelial cells suspicious urothelial carcinoma prostatitis dx 2025 fibrillation amiodarone tunnel syndrome artery disease cabg 2070 svg lad svg om svg pda cath 2086 severe native disease occluded svg rca om patent svg lad redo cabg hernia insufficiency social history social history lives apartment service pays people come help needed son long term relationship year smoker quit years ago denies alcohol sings acapella hospital rehab family history noncontributory physical exam admission physical exam vitals 52 100 general alert oriented acute distress sleepy bed heent sclera anicteric mmm oropharynx clear eomi perrl neck supple jvp elevated lad cv bradycardic diastolic murmur lusb radiating lungs clear auscultation bilaterally wheezes rales rhonchi abdomen protuberant soft bowel sounds present organomegaly rebound guarding gu yellow urine foley ext warm perfused 2 pulses clubbing cyanosis edema neuro intact strength extremities grossly normal sensation 2 reflexes bilaterally gait deferred discharge pe vss cv systolic murmur 12 28 brisk carotid upstroke lungs ctab wrr ntnd active bs cva tenderness unchanged pertinent results admission labs 2100 8 8 urine trans 2100 8 8 urine 2100 8 8 urine sp un 2100 8 8 plt 2100 8 8 2100 8 8 2100 8 8 urea total 25 anion 2100 8 8 2100 8 8 2100 8 10 impression 1 evidence pyelonephritis perinephric focal fluid collections note ultrasound relatively low sensitivity detection pyelonephritis absence significant phlegmon abscess 2 x x cm anechoic structure likely representing small renal cyst lower pole left kidney 3 enlarged prostate 2100 8 8 urine final report 2100 8 10 urine culture final 2100 8 10 escherichia coli presumptive identification cefazolin interpretative criteria based dosage regimen 2 g sensitivity testing available request sensitivities mic expressed escherichia coli 8 s 4 s 4 s 1 s 1 s 1 s s 1 s s 32 s 1 s 1 s bc pending 8 9 8 10 brief hospital course 85 yo m pmhx bladder tumors prior episode bacterial prostatitis cad cabg af ckd htn transferred osh urosepsis found gnr bacteremia stabilized micu fluid resucitation antibiotics continued floor switching oral antibiotics urosepsis likely secondary prostatitis altered mental status patient known bladder tumors noted increased urinary urgency incontinence days prior admission met sepsis criteria osh fever tachypnea leukocytosis positive ua ultimately grew ecoli gnr bacteremia started zosyn osh switched cefepime initially micu cultures 1280 3075 3549 hospital pending time discharge despite multiple calls including discharge 8 faxed 18 send note patients pcp alerting situation 18 patient grew pan sensitive coli urine surveillance blood cultures growth date wbc normalized afebrile mental status baseline medical floors addition psa checked elevated conversations stitle 79 patients urologist negative renal bacterial prostatitis thought ultimate source patients infection patient sent home 3 weeks cipro interaction coumadin noted thought best drug concentrates prostate covers patients coli left leg pain patient describes 1 month history left leg pain radicular pattern radiating leg pain improved unloading spine bending forward somewhat consistent spinal stenosis considered sciatic nerve pain possibility pt worked patient indicated safe home wheeled walker home safety evaluation consideration home outpatient pt patient sent home low dose oxycodone tolerated house good relief bowel regimen advised consider follow orthopedist consideration management injection surgery afib patient rhythm controlled amiodarone continued inpatient coumadin increased 3 mg qd titration outpatient likely necessary given cipro 3 weeks pcp stitle 3855 follow inr given prescription days transitional issues follow patient blood cultures hospital 3075 3549 location un 47 speciated grew gnr note patient pending blood cultures 18 8 9 8 10 pending time discharge summary need follow pcp 11 23 weeks inr checked prior visit medications admission preadmission medications listed correct complete information obtained patientwebomr 1 amiodarone 200 mg po daily 2 amlodipine 5 mg po daily hold 3 losartan potassium 100 mg po daily hold 4 finasteride 5 mg po daily 5 fish nf 144 216 mg oral daily 6 aspirin 81 mg po daily 7 warfarin 2 mg po day 8 warfarin 3 mg po day 9 oxazepam 15 mg po hs prn anxiety 10 cetirizine nf 10 mg oral qday prn allergies 11 vitamin d 1000 unit po daily 12 multivitamins 1 tab po daily 13 metamucil nf psyllium psyllium husk psyllium seed sugar gram oral qday 14 ranitidine 150 mg po bid prn reflux 15 cialis nf tadalafil 20 mg oral prn 16 terbinafine 1 cream 1 appl tp discharge medications 1 amiodarone 200 mg po daily 2 aspirin 81 mg po daily 3 finasteride 5 mg po daily 4 losartan potassium 100 mg po daily hold 5 multivitamins 1 tab po daily 6 terbinafine 1 cream 1 appl tp 7 vitamin d 1000 unit po daily 8 ciprofloxacin hcl 500 mg po duration 21 days rx ciprofloxacin 500 mg 1 mouth 12 hours disp 42 tablet 9 oxycodone immediate release 5 mg po prn severe pain rx oxycodone 5 mg half mouth 6 hours disp 20 tablet 10 amlodipine 5 mg po daily hold 11 cetirizine nf 10 mg oral qday prn allergies 12 cialis nf tadalafil 20 mg oral prn 13 fish nf 144 216 mg oral daily 14 metamucil nf psyllium psyllium husk psyllium seed sugar gram oral qday 15 oxazepam 15 mg po hs prn anxiety 16 ranitidine 150 mg po bid prn reflux 17 warfarin 3 mg po 18 outpatient lab work draw inr 2100 8 13 fax office patient pcp 3857 3855 phone 1 3858 fax 1 3859 atrial fibrillation discharge disposition home service facility location un 1110 vna discharge diagnosis acute bacterial prostatitis coli bacteremia sepsis hypotension coronary artery disease hypertension discharge condition mental status clear coherent level consciousness alert interactive activity status ambulatory requires assistance aid walker cane discharge instructions came 18 outside hospital low blood pressure bacteria blood icu antibiotics condition improved bacteria blood likely came infected prostate antibitoics total 3 additional weeks sent home home pt follow doctors medication changes 1 cipro 500 mg 3 weeks dose 9 cipro 2 hours taking milk iron calcium 2 coumadin 3 mg qd 3 tylenol 650 prn mild moderate pain counter 4 oxycodone 5 mg prn severe pain 5 docusate 100 constipation narcotics counter followup instructions lf lf location titles 3860 titles 662 center address street 3861 location un numeric identifier 3862 phone 1 3858 appointment thursday 2100 8 19 department radiology tuesday 2100 9 7 radiology mri 1 590 building sc hospital ward 23 clinical ctr location un 861 campus east best parking hospital ward 23 garage department surgical specialties tuesday 2100 9 7 1 pm 275 276 1 277 building 29 location un campus east best parking hospital ward 23 garage\n",
            "Processing row 4: admission date 2156 8 1 discharge date 2156 8 12 service medicine allergies patient recorded having known allergies drugs lf 358 chief complaint pain major surgical invasive procedure ercp stent placement sphincterotomy seconary supratheraputic inr history present illness hpi man cad cabg 2141 mult pci ischemic cmy lvef 35 afib coumadin possible mr diet controlled cri gout presented hospital hospital 4 2156 8 1 pain epigastrium chest transferred concern cholangitis patient reports intermittent discomfort chest epigastrium began 1 2 weeks ago precipitating factors exertion food describes cramping pain radiation r shoulder arms felt worse night lying pain felt different prior angina treated tylenol relief night pta pain recurred unable sleep wife called ems ni 4045 hospital hospital ros notable chronic doe prehaps increase baseline increase rle swelling chronic l r edema prior surgeries denies diarrhea constipation changes stool urine color frequency erythema swelling left digit started 3 weeks ago thinks bug bite hospital hospital found ekg change normal cardiac enzymes cxr showed bilateral pleural effusions l felt chf exam given lasix diuresis labs came wbc 88 pmns 8 bands abnl lfts ast 122 alt 54 ap 307 tbili dbili tprot alb lipase elevated 2214 bun cr elevated unclear chronic acute abd revealed small gallstones gallbladder thickening gb walls biliary dilatation received levaquin ctx vomited received zofran inr given 5 mg vit k sq ffp discussion ercp fellow 18 patient transferred care plan ercp past medical history cad cabg 2141 mult pci ischemic cardiomyopathy lvef 35 cardiac murmur consistent mr afib coumadin diet controlled ckd gout social history sh lives home wife location un 1121 previously smoked pipes cigars quit years ago restarted quit 2 weeks ago rare etoh use illicits worked master craftsman gte ago retired crafts things enjoyment garden work outside family history noncontributory physical exam afebrile mild hypertension sats 90 room air gen pleasant cooperative heent poor dentition op clear anicteric sclera conjunctiva nonerythematous neck supple carotid bruit heart regular holosystolic murmur apex radiating carotids lungs clear bilaterally abd soft nontender mildly distended appropriate bowel sounds ext edema rash lesion gait unsteady pertinent results 2156 8 1 urea total 28 anion 2156 8 1 alk 2156 8 1 2156 8 1 2156 8 1 nuc brief hospital course known lastname 87 year old male admitted 2156 8 4 trasfer 4046 hospital unit 153 1 septicemia ercp revealed obstructive gallstone stent placed outside blood cultures positive pan sensitive coli received antibiotics including initially rocephin outside hospital ampicillin transfer ciprofloxacin 8 5 stop date planned 2156 8 16 follow appointment outpatient repeat ercp stent removal planned 4 12 weeks post discharge initial ercp date 2156 8 4 improved dramatically ercp abdominal pain tolerating diet discharge 2 acute renal failure improved baseline lasix supportive care sepsis ace inhibitor digoxin held 3 cardiomyopathy question acs admission ecg changes symptoms consistent pancreatitis antiplatelet medications held interventions held 10 days post ercp beta blocker restarted improved inital presentation statin added hospitalization followed liver enzymes lipid profile 5 weeks discharge home dose lasix restarted days prior discharge 4 atrial known lastname received ffp presentation order perform ercp procedure restarted home dose 4 mg po qhs inr affected simulateous administration ciprofloxacin supratheraputic 2155 8 12 held night prior discharge instructions rehab facility follow inr closely adjust coumadin appropriately rate controlled appropriately hospitalization digoxin held secondary renal insufficiency restarted discretion primary physician 5 hypertension mildly elevated blood pressures hospitalization controlled lasix metoprolol ace inhibitor held initially renal insufficiency restarted day prior discharge checked week restarting ace instructions given rehab facility medications admission unknown discharge medications 1 famotidine 20 mg tablet sig 1 tablet po 24 hours 2 metoprolol tartrate 50 mg tablet sig 1 tablet po bid 2 times day 3 senna mg tablet sig 1 tablet po bid 2 times day needed constipation 4 docusate sodium 100 mg capsule sig 1 capsule po bid 2 times day needed constipation 5 ciprofloxacin 500 mg tablet sig 1 tablet po 12 hours 5 days 6 clopidogrel 75 mg tablet sig 1 tablet po daily daily 7 simvastatin 10 mg tablet sig 2 tablet po daily daily 8 furosemide 20 mg tablet sig 1 tablet po daily daily 9 lisinopril 5 mg po qday discharge disposition extended care facility location un 4047 nursing rehabilitation center location un 4047 discharge diagnosis 1 gallstone pancreatitis ercp stent placement 2 sepsis resolved 3 acute renal failure resolved discharge condition stable discharge instructions hospitalized gallstone pancreatitis icu acute renal failure recovered normal kidney function discharged rehabilitation facility order gain strength continue receive help medications followup instructions follow stitle 3278 week evaluated outpatient obstructive sleep apnea gastroenterology outpatient clinic follow appointment ercp common bile duct stent removal\n",
            "[['admission', 'discharge', 'service medicine', 'patient', 'allergies drugs', 'chief complaint', 'mental status', 'hypotension', 'surgical invasive procedure history', 'illness age', 'refractory', 'hodgkins lymphoma', 'ems', 'hypotensive', 'incontinant', 'stool', 'treated', 'vanco', 'ativan', 'morphine', 'agitation', 'admitted hospital unit', 'course', 'ceftazadime', 'vancomycin', 'urosepsis', 'course', 'metronidazole', 'empiric treatment', 'loose stools', 'elevated', 'wbc count diff assays', 'negative', 'stabilized', 'transferred floor', 'time transfer', 'active issues', 'nutritional status thrombocytopenia', 'anemia', 'floor', 'episode', 'afib rvr', 'hypotension', 'respiratory distress', 'fluid resuscitation concern syndrome', 'pauses', 'digoxin', 'readmitted', 'micu', 'micu', 'vancomycin', 'sites', 'infection', 'erosions', 'breasts right', 'micu', 'course', 'hypotension', 'low', 'hypovolemia', 'baseline', 'nitrogenous urine output', 'amiodarone', 'daily', 'days', 'downward', 'medical history', 'nodular sclerosing', 'hodgkins lymphoma', 'lymphadenopathy', 'treated', 'local radiotherapy', 'progression', 'treated', 'cytoxan', 'prednisone', 'treated', 'radiation therapy', 'hypoxemia somnolence generalized edema anasarca', 'discharged constant', 'trial', 'low blood counts', 'chlorambucil', 'daily', 'days', 'procarbazine', 'daily', 'days', 'velban', 'day', 'chemotherapy', 'poor response', 'sided chest', 'lytic lesions', 'radiation therapy', 'right rib interval', 'decrease', 'vertebral lesions', 'lower extremity cellulitis', 'gerd arthritis', 'chronic ble edema hypothyroidism', 'constipation', 'social history', 'home health care', 'son ni', 'care children', 'alcohol illicit drug', 'family history', 'noncontributory', 'physical exam', 'physical exam', 'elderly', 'female', 'minimally reponsive verbal stimuli', 'tactile', 'stimulation', 'moist', 'mucous membranes', 'carotid pulses', 'lungs', 'abd soft', 'non tender percussion ext pitting edema feet bilaterally nonpalpable', 'capillary refill bilaterally neuro', 'pupils', 'bilaterally', 'painful', 'increased', 'tone mute', 'bilaterally toes', 'physical exam', 'time transfer', 'elderly', 'female', 'minimally reponsive verbal stimuli', 'tactile', 'dry mucous membranes', 'carotid pulses', 'jvp', 'breath sounds bases', 'bilaterally', 'abd soft distended', 'active bowel sounds', 'non tender percussion ext pitting edema extremities', 'bilaterally nonpalpable', 'capillary refill bilaterally neuro', 'pupils 3 4', 'bilaterally', 'painful', 'stimuli', 'reflexes bilaterally physical exam transfer', 'micu', 'temp bp', 'lnc', 'gen pleasant comfortable nad', 'somnolent', 'heent', 'eomi', 'anicteric tachy', 'lesions', 'neck supraclavicular cervical lymphadenopathy jvd resp occ crackle bases', 'patient', 'cooperative exam', 'involvement', 'upper limbs', 'skin rashes', 'jaundice neuro', 'somnolent', 'neuro', 'somnolence pertinent results', 'consolidation', 'routine', 'pa lateral', 'films', 'evaluation', 'echo left atrium', 'atrial septal defect', 'color', 'doppler left ventricular wall', 'left ventricular cavity', 'left ventricular systolic function', 'free wall motion normal', 'valve leaflets', 'trace aortic regurgitation', 'mitral valve leaflets', 'physiologic', 'mitral regurgitation', 'pulmonary artery', 'pericardial effusion', 'endocarditis', 'prophylaxis', 'recommendations', 'echo findings', 'prophylaxis', 'clinical decisions', 'prophylaxis', 'clinical', 'echocardiographic', 'data', 'study images', 'review', 'hospital course', 'age', 'nodular sclerosing hodgkin lymphoma', 'urosepsis', 'icu hypotension', 'goals care', 'patient', 'long hospital course', 'family meetings reagarding', 'goals care', 'patient', 'icu transfers', 'pressors', 'comfort', 'patient', 'patient', 'levophed hypotension', 'decision medically futile', 'escalate care care', 'family', 'autopsy', 'afib', 'transient', 'controlled', 'diltiazem', 'metoprolol', 'spontaneous', 'conversion', 'pauses', 'bradycardia', 'junctional escape', 'digoxin', 'patient', 'micu', 'amiodarone', 'gtt', 'amiodarone', 'patient readmitted', 'increased', 'pauses', 'amiodarone', 'patient', 'anemia', 'thrombocytopenic admission', 'secondary marrow infiltration lymphoma', 'transfused', 'plt 1 unit', 'transfusion', 'threshold', 'trend', 'platelets', 'transfuse bleeding', 'platelet count', 'platelets', 'patient', 'prbc transfusions', 'hypotension', 'hypotensive episodes', 'furosemide', 'responsive', 'fluid', 'blosues', 'echo', 'impaired', 'lv relaxation', 'elevated', 'phenylephrine', 'gtt', 'weaned hypotension', 'admission', 'secondary', 'systemic vasodilation', 'levophed decision escalate care infection', 'elevated', 'infectious', 'sources', 'hypotension', 'skin erosions', 'breasts', 'breath sounds pna vanc', 'piptaz', 'cultures', 'blood urine', 'sputum', 'point cdiff', 'flagyl 1', 'skin swab hypernatremia', 'hypernatremic admission', 'free water', 'intake', 'free water', 'mental status', 'increased', 'lethargy', 'baseline admission', 'metabolic encephalopathy', 'respiratory distress', 'admission', 'patient', 'labored breathing', 'ns hypotension flash pulmonary edema diuresis furosemide', 'gtt lead hypotension', 'resuscitation lead', 'respiratory distress', 'floor', 'event', 'flow mask icu', 'weaned', 'increasing', 'requirements', 'acute renal failure', 'cr admission', 'baseline', 'baseline', 'dehydration hypotension sepsis', 'hospital course', 'patient', 'hypotensive creatinine', 'secondary atn hypothyroidism', 'treated', 'levothyroxine', 'elevated', 'home dose', 'anasarca', 'edema', 'bilateral', 'pleural effusions', 'malnutrition', 'low albumin admission', 'intake', 'diuresis', 'difficult', 'hypotension', 'urosepsis', 'admitted', 'hypotension urosepsis', 'pressor', 'urine cultures', 'positive', 'treated', 'vancomycin', 'ceftazidime', 'days', 'yeast', 'treated', 'right acetabulum', 'medial', 'osseous', 'right sacral ala iliac bone', 'patient pain', 'controlled', 'fentanyl lidocaine', 'bilateral', 'pleural effusion', 'agressive', 'sepsis hypoalbuminemia', 'effect significant', 'micu', 'development', 'hypotension', 'furosemide', 'improved', 'unchanged', 'nodular sclerosing hodgkin lymphoma', 'oncology interventions', 'bone marrow', 'anemia thrombocytopenia', 'hemolysis', 'treatment', 'oncology coagulopathy', 'mild', 'nutritional deficiency', 'po', 'intake', 'trend lfts', 'coags medications', 'admission', 'medications', 'admission', 'levothyroxine', 'daily', 'docusate sodium', 'omeprazole', 'ferrous sulfate', 'daily', 'qid', 'ultram', 'lasix', 'senna', 'aspirin', 'potassium chloride', 'multivitamin medications', 'acetaminophen', 'affected', 'folic acid 1', 'cap po daily 5', 'ipratropium bromide', 'neb 1 neb', 'bisacodyl', 'daily', 'tab', 'bid constipation', 'docusate sodium', 'bid', 'albuterol', 'neb soln', 'neb', 'metronidazole', 'flagyl', 'fentanyl', 'lidocaine', 'patch', 'ptch', 'right hip day', 'sarna lotion 1 appl', 'levothyroxine sodium', 'pantoprazole', 'iv discharge', 'medications', 'patient', 'discharge disposition', 'care discharge', 'urosepsis', 'aspiration pneumonitis', 'atrial fibrillation rvr lymphoma', 'condition', 'patient', 'discharge instructions', 'patient', 'followup', 'instructions', 'patient', 'initials'], ['admission', 'discharge', 'sex', 'allergies', 'iron dextran complex', 'chief complaint', 'respiratory failure', 'surgical invasive procedure bronchoscopy intubation hemodialysis', 'illness', 'female', 'egfr', 'wild type', 'respiratory distress', 'patient cough', 'dialysis coughing', 'graft', 'short breath', 'ems', 'presentation', 'eyes', 'cousin', 'lung cancer', 'right upper lobe mass adjacent', 'nodes', 'patient', 'month', 'vinorelbin', 'palliative chemotherapy', 'weeks', 'patient', 'dry weight', 'course', 'initial', 'triggered', 'respiratory distress', 'eyes', 'open question status', 'physician', 'spoke doctor', 'intubated', 'intubated', 'etomidate', 'sedation', 'propofol', 'intubation', 'vent', 'rul opacity', 'ceftriaxone', 'levofloxacin', 'vancomycin', 'hcap ekg', 'sinus tach twi', 'peaked', 'patient sedation', 'ventilator renal', 'left graft', 'functioning', 'placed rij line dialysis access dialysis going', 'hypotensive maps', 'propofol', 'dialysis', 'patient', 'bronchoscopy bal', 'rl apical segmental occlusion tumor 90 anterior segment occlusion patent posterior segment pressure', 'review systems', 'patient', 'medical history', 'lymphangitic', 'cell renal carcinoma', 'nephrectomy type 2 retinopathy', 'neuropathy airway disease', 'copd', 'poorly', 'controlled', 'hypertensive', 'anemia', 'lvef', 'pulmonary artery hypertension', 'lower pain', 'biopsy', 'social history', 'roomate', 'family carnival worker traveled', 'pack yr history ssi', 'family history multiple', 'family members', 'cousins kidney disease', 'dialysis', 'breast cancer', 'physical exam', 'cmv', 'peep', 'intubated', 'lungs', 'auscultation', 'bilaterally wheezes rales ronchi cv', 'regular rate rhythm', 'rubs gallops', 'port test', 'abdomen', 'soft bowel sounds', 'tenderness', 'organomegaly gu foley ext warm perfused', 'graft bruit thrill rij', 'admission', 'labs', 'blood plt', 'blood', 'blood tear stitle', 'blood', 'blood', 'blood', 'blood', 'blood', 'blood', 'blood tidal', 'blood', 'blood', 'blood cardiac enzymes', 'blood', 'blood', 'blood', 'blood bronchial washing', 'negative', 'malignant cells', 'admission', 'sinus', 'intraventricular conduction delay left', 'wave abnormalities', 'intraventricular conduction delay left ventricular hypertrophy', 'ischemia', 'clinical correlation', 'sinus', 'wave abnormalities', 'impression', 'pulmonary edema dense consolidation right', 'edema pneumonia', 'mass lesion', 'echo', 'left atrium', 'normal size', 'symmetric left ventricular hypertrophy', 'cavity size', 'left ventricular systolic function', 'moderately depressed', 'right ventricular chamber size', 'free wall motion normal', 'aortic stenosis', 'trace aortic regurgitation', 'mitral valve leaflets', 'mitral valve prolapse', 'physiologic', 'mitral regurgitation', 'tricuspid valve leaflets', 'pulmonary artery systolic pressure', 'pericardial effusion impression', 'global hypokinesis lateral wall function', 'mitral regurgitation', 'opacification right upper lung', 'right mediastinal shift', 'findings', 'interval development', 'atelectasis', 'significant', 'volume loss', 'hemorrhage', 'recommended', 'position tubes lines', 'left perihilar region', 'opacities', 'assessment', 'female', 'rul htn', 'acute respiratory distress', 'opacification', 'secondary', 'pneumonia', 'neutropenia', 'respiratory distress', 'intubated ventilated', 'pressure support trial', 'extubated', 'discussion', 'patient', 'extubated', 'trial pressure support', 'respiratory distress', 'multifactorial', 'opacification', 'pneumonia', 'bronchscopy pulmonary edema', 'lymphangitic', 'goals care', 'family hcp decision reintubate', 'cmo', 'morphine', 'oral solution', 'scopolamine', 'patch secretion control', 'morphine', 'gtt bolus', 'morphine', 'tachypnea', 'patient', 'sepsis', 'secondary pneumonia', 'coli bacteremia', 'patient leukocytosis fever micu', 'treated', 'changed', 'data', 'admission', 'vinrelbin chemo 2', 'weeks', 'pta', 'bacteremia', 'pulmonary system decision', 'discontinued', 'tylenol', 'metabolic alkalosis', 'metabolic acidosis', 'resolved', 'dialysis', 'respiratory acidosis', 'secondary', 'hypoventilation', 'blood draws', 'lytes', 'discontinued', 'patient', 'cmo hypotension', 'patient issues', 'dependent', 'hypotension', 'micu', 'course', 'patient', 'resuscitated', 'moderate', 'hypokinesis', 'myocardial depression', 'sepsis', 'patient', 'discontinued', 'ekg changes', 'admission state acute illness', 'ischemia', 'ekg changes', 'morning', 'troponins bland acute plaque', 'rupture', 'cardiac medications', 'micu', 'stay', 'cmo status', 'plavix', 'lipitor', 'heparin gtt chronic kidney disease', 'hd hd performed renal micu stay', 'medications', 'renally', 'dosed', 'nephrotoxins', 'discontinued', 'patient', 'cmo stage', 'chemotherapy', 'patient', 'anemia', 'baseline', 'stable', 'evidence', 'acute blood loss', 'patient', 'chronic heart failure systolic ef 30 mr stitle', 'active signs', 'transient diastolic function', 'pulmonary edema echo', 'mr history', 'reactive airway disease', 'ipratropium', 'diabetes', 'oral hypoglycemics', 'cmo goals care', 'pressors', 'health deteriorated', 'patient', 'cmo family', 'hcp light pneumonia', 'treat', 'setting stage', 'transferred medicine', 'family', 'bedside', 'patient', 'medications', 'comfort', 'tylenol', 'morphine sulfate', 'oral solution', 'ativan', 'haldol', 'counseling family stay', 'medications', 'admission', 'albuterol sulfate', 'provider', 'mcg', 'hfa', 'inhaled 4', 'shortness breath wheezing', 'acid nephrocaps', 'provider', 'capsule 1 mouth', 'calcium acetate', 'provider', 'capsule 2 caps', 'daily', 'furosemide', 'lasix', 'prescribed', 'provider', 'tablet', 'day', 'gabapentin', 'prescribed', 'provider', 'capsule 2 mouth', 'day', 'hair prosthesis', 'scalp', 'alopecia icd 9 lactulose 10 ml', 'solution', 'mouth', 'day', 'constipation', 'metoprolol', 'succinate', 'tablet', 'sustained', 'mouth', 'day', 'omeprazole', 'prescribed', 'provider', 'capsule', 'day', 'oxycodone', 'tablet', 'sustained', 'mouth', 'day', 'oxycodone', 'tablet', 'pain', 'pain', 'prochlorperazine maleate', 'tablet', 'nausea', 'simvastatin', 'tablet', 'day', 'tiotropium bromide', 'spiriva', 'handihaler', 'capsule device 1', 'aspirin', 'prescribed', 'provider', 'tablet', 'docusate sodium', 'provider', 'capsule', 'mouth', 'daily', 'discharge disposition', 'post obstructive pna setting stage', 'iv nsclc', 'discharge condition', 'followup'], ['admission', 'discharge', 'sex', 'bactrim', 'ciprofloxacin', 'codeine lf 1162 chief complaint', 'ams', 'surgical invasive procedure history', 'illness', 'seizure', 'unwitnessed', 'seizure', 'crawl window yell', 'ems', 'hospitalized malaise', 'renal failure', 'po', 'intake', 'hypotension', 'adrenal insufficiency', 'steriods', 'ivf', 'cefuroxime', 'care facility', 'ems', 'speech slurred', 'filthy appt', 'feces', 'legs cat feces', 'urine feces', 'initial', 'inr tox screen', 'benzos opiates', 'serum', 'cefuroxime', 'solumedrol', 'linezolid', 'furhter management', 'course', 'initial', 'sbp', 'ivf', 'ra', 'increased', 'rhabdo acute chronic renal failure', 'aggressive fluid resuscitation', 'renal function', 'equivocal', 'colonization', 'gram positive cocci bacteremia', 'vancomycin', 'speciation', 'transferred floor', 'vancomycin', 'cough chest', 'pain', 'palpitations', 'abdominal dysuria', 'ha', 'visual', 'historian', 'paranoid', 'tangential speech', 'evaluate', 'medical history', 'anticoagulation', 'linezolid disorder', 'disease', 'chronic steroids', 'quiescent', 'sulfasalazine', 'nodules', 'breast mass', 'diagnosed', 'disease hyperparathyroidism', 'cholecystectomy', 'total knee replacement oa', 'knee', 'obesity', 'social history', 'cats', 'feces', 'elder services', 'smoked', 'patient', 'social situation', 'public health department', 'condemning house', 'family history physical exam pe vs bp hr rr', 'gen', 'apparent distress', 'heent', 'resp ctab', 'effort', 'abd distended soft non tender nl bs ext neuro', 'cns 2', 'intact', 'plt plt', 'alk', 'cardiac', 'blood', 'blood', 'blood', 'blood anemia', 'vit', 'discharge ct head 7 5', 'evidence', 'intracranial hemorrhage', 'mass effect', 'midline structures', 'hydrocephalus acute', 'vascular', 'infarct doctor differentiation', 'unchanged', 'appearance', 'age', 'atrophy', 'carotid siphons', 'bilaterally soft tissues', 'osseous structures', 'unremarkable', 'paranasal sinuses', 'mastoid air cells', 'aerated impression', 'findings', 'acute fracture dislocation', 'degenerative joint', 'degenerative disc disease', 'prevertebral soft tissue', 'intrathecal sac', 'examination', 'artifact shoulders', 'acute fracture dislocation', 'findings', 'linear atelectasis', 'left base lungs', 'mild', 'perihilar vessels', 'engorgement', 'pulmonary vasculature', 'mild fluid', 'patient', 'renal failure', 'evidence', 'pneumothorax cardiomediastinal silhouette hilar contours', 'right effusion', 'left costophrenic angle', 'film', 'surgical hardware right total shoulder replacement', 'evidence', 'pneumonia', 'left lower lobe linear atelectasis 2', 'perihilar haziness congestion pulmonary vasculature', 'fluid overload', 'patient', 'renal failure', 'ecg sinus rhythm', 'borderline', 'premature', 'echo conclusions', 'images', 'suboptimal', 'technical quality', 'focal wall motion', 'abnormality', 'left ventricular systolic function', 'pericardial effusion brief hospital course', 'paranoid seizure ckd pe', 'anticoagulation', 'days', 'acute chronic renal failure', 'apparent gram positive', 'patient', 'admitted hospital unit', 'transferred floor', 'issues', 'admission', 'patient', 'home etiology', 'secondary seizure', 'patient', 'klonopin', 'seizure', 'prophylaxis', 'patient', 'utox', 'positive', 'opiates', 'metabolic derangements', 'evidence', 'trauma', 'cardiac enzymes', 'cycled', 'flat ekg', 'baseline', 'patient', 'mental status', 'patient', 'dilantin', 'seizure', 'dilantin', 'loaded', 'evening', 'dilantin', 'dosing', 'patient', 'keppra', 'neuro', 'discontinued', 'dosing', 'patient', 'coumadin', 'dosing', 'dilantin', 'interaction', 'keppra', 'patient', 'dose', 'evidence', 'activity', 'renal creatinine', 'acute chronic renal failure', 'secondary', 'dehydration', 'evidence', 'muddy', 'brown casts', 'rhadbomyolysis', 'patient', 'aggressive fluid resuscitation', 'hours', 'ivf', 'nephrology', 'patient', 'hospitalization renal failure', 'time discharge', 'diuresis', 'lytes', 'repleted nsaids', 'sulfasalazine', 'patient creatinine', 'hospitalization discharge', 'hypotension', 'sbp', 'fluids febrile', 'relative adrenal insufficiency', 'hypotension steroids', 'admission', 'volume', 'adrenal insufficiency', 'intake', 'days', 'aggressive hydration home dose', 'prednisone', 'crohn', 'empiric', 'vancomycin', 'discontinued', 'patient history', 'leukocytosis', 'afebrile', 'patient', 'day', 'culture grew gram negative rods', 'coli', 'patient', 'levofloxacin', 'sensitivities', 'resistance', 'iv ceftriaxone', 'ceftriaxone', 'dose', 'unasyn', 'levofloxacin', 'patient', 'spiking temperatures', 'ams', 'tachycardia blood cultures', 'sensitivities', 'consult', 'week', 'ceftriaxone', 'days', 'picc line', 'ir', 'antibiotic therapy', 'crohn sulfasalazine', 'diarrhea', 'crohn', 'symptoms', 'prednisone', 'daily history', 'anxiety', 'paranoia admission', 'patient', 'paranoid', 'filthy apartment admission', 'services', 'paranoia head ct', 'psych', 'evaluated', 'standing', 'haldol', 'haldol', 'agitation', 'clonopin 7 7', 'improvement', 'mental status', 'patient', 'paranoia', 'haldol', 'discontinued', 'doxapin restoril', 'patient', 'baseline', 'patient', 'capacity', 'decisions', 'anticoagulation', 'coumadin', 'coumadin outpatient dose 2', 'daily', 'sc', 'therapeutic', 'goal', 'hypothyroidism tsh wnl', 'levothyroxine', 'asthma', 'home regimen', 'singulair', 'prednisone', 'crohn', 'patient', 'ems', 'multiple', 'animals', 'urine feces', 'public health', 'clean house', 'patient', 'capacity', 'return current living situation', 'rehab', 'housing', 'medications admission', 'levothyroxine', 'clonazepam', 'methylphenidate', 'citalopram', 'montelukast', 'daily', 'doxepin', 'warfarin 2', 'prednisone', 'daily', 'dose', 'nabumetone', 'sulfasalazine', 'cyclobenzaprine', 'hydromorphone', 'prn discharge medications', 'levothyroxine', 'tablet', 'tablet', 'daily daily 2', 'clonazepam', 'tablet', 'tablet', 'day', 'methylphenidate', 'tablet', 'tablet', 'daily daily', 'montelukast', 'tablet', 'tablet', 'daily daily', 'prednisone', 'tablet', 'tablet', 'daily', 'daily', 'pantoprazole', 'tablet', 'delayed', 'tablet', 'delayed', 'sulfasalazine', 'tablet', 'tablet', 'bid', 'day', 'doxepin', 'capsule sig 2 capsule', 'bedtime', 'temazepam', 'capsule', 'bedtime', 'acetaminophen', 'tablet', 'tablet', 'pain fever 11 miconazole nitrate 2 powder', 'topical', 'day', 'warfarin 2', 'tablet', 'tablet', 'bedtime', 'levetiracetam', 'tablet', 'tablet', 'docusate sodium', 'capsule', 'capsule', 'bid', 'day', 'bisacodyl', 'tablet', 'delayed', 'tablet', 'delayed', 'daily daily', 'piggyback', 'intravenous', 'days', 'days', 'lovenox', 'subcutaneous day', 'inr', 'coumadin', 'discharge disposition', 'care facility', 'nursing center', 'location', 'discharge diagnosis', 'urosepsis', 'acute renal failur 3', 'seizure', 'secondary pulmonary ebmolism', 'asthma crohn disease', 'depression adrenal insufficiency', 'stable', 'patient', 'rehab facility', 'iv ceftriaxone', 'weeks', 'duration followup', 'primary care doctor', 'gastroenterologist seizures', 'neurology'], ['admission', 'discharge', 'sex', 'service', 'allergies', 'procainamide lf 3853 chief complaint', 'mental status', 'hypotension', 'surgical invasive procedure history', 'illness', 'htn transferred', 'concern urosepsis', 'day', 'admission shaking chills', 'mental status', 'reports', 'urinary incontinece', 'days', 'abnormal', 'dysuria', 'reports', 'awaking', 'middle night shaking chills', 'arrival', 'febrile', 'dose', 'tylenol', 'positive uti bp', 'fluids improvement bp head ct', 'mental status', 'anticoagulation report', 'transferred care', 'providers', 'arrival', 'febrile', 'rectally', 'tylenol', 'bolus fluid', 'urine cultures', 'urosepsis', 'arrival', 'micu', 'patient', 'chronic left sided pain', 'suprapubic pain', 'nausea vomiting flank pain', 'hematuria', 'changes', 'urine color', 'negative', 'medical history', 'bladder', 'urine cytology', 'clusters', 'atypical', 'urothelial cells', 'urothelial carcinoma', 'prostatitis', 'fibrillation amiodarone tunnel syndrome artery disease', 'native disease', 'cabg hernia', 'social history', 'social history', 'apartment service', 'people', 'relationship', 'year', 'smoker quit', 'years', 'alcohol sings', 'acapella hospital', 'family history', 'noncontributory', 'physical exam', 'physical exam', 'oriented acute distress', 'bed heent sclera anicteric', 'neck supple jvp', 'bradycardic diastolic', 'lungs', 'auscultation', 'bilaterally wheezes rales', 'soft bowel sounds', 'organomegaly', 'rebound guarding', 'gu yellow urine foley ext warm', 'reflexes', 'bilaterally gait', 'carotid upstroke', 'lungs ctab', 'tenderness', 'unchanged', 'admission', 'labs', 'urine trans', 'urine', 'urine sp', 'urea', 'anion', 'impression', 'evidence', 'pyelonephritis', 'perinephric', 'focal fluid', 'ultrasound', 'sensitivity', 'pyelonephritis', 'absence', 'phlegmon abscess', 'anechoic structure', 'small renal cyst', 'lower pole left kidney 3', 'prostate', 'urine', 'report', 'urine culture', 'escherichia coli', 'presumptive identification', 'interpretative criteria', 'dosage regimen', 'sensitivity testing', 'sensitivities', 'mic', 'expressed', 'escherichia coli', 'hospital course', 'pmhx', 'bladder tumors', 'episode', 'bacterial prostatitis', 'cad cabg', 'ckd htn', 'urosepsis', 'bacteremia', 'stabilized', 'micu', 'fluid resucitation', 'floor switching oral antibiotics', 'urosepsis', 'secondary prostatitis', 'mental status', 'patient', 'bladder tumors', 'increased', 'urinary urgency', 'incontinence', 'days', 'admission', 'sepsis criteria', 'fever tachypnea leukocytosis', 'positive', 'ecoli', 'bacteremia', 'cefepime', 'micu', 'cultures', 'hospital', 'discharge', 'patients', 'pcp', 'alerting situation', 'patient', 'coli', 'urine', 'surveillance', 'blood cultures', 'growth', 'afebrile', 'mental status', 'baseline', 'medical floors', 'psa', 'elevated', 'conversations', 'patients', 'negative renal', 'bacterial prostatitis', 'patients', 'infection', 'patient', 'cipro', 'interaction', 'coumadin', 'drug concentrates', 'prostate', 'patients', 'left leg', 'patient', 'month', 'left leg', 'pain', 'radicular pattern', 'leg pain', 'unloading', 'spine bending forward', 'spinal stenosis', 'sciatic nerve', 'patient', 'home wheeled', 'evaluation', 'patient', 'home low', 'orthopedist', 'consideration management', 'injection surgery', 'afib', 'patient rhythm', 'amiodarone', 'inpatient', 'coumadin', 'increased', 'titration', 'outpatient', 'cipro', 'weeks', 'inr', 'prescription', 'days', 'transitional issues', 'patient', 'blood cultures', 'hospital', 'location', 'speciated', 'patient', 'blood cultures', 'time discharge', 'pcp', 'weeks', 'inr', 'visit', 'medications', 'admission', 'preadmission medications', 'complete', 'information', 'patientwebomr', 'amiodarone', 'amlodipine', 'daily', 'losartan', 'daily', 'finasteride', 'fish', 'oral daily', 'aspirin', 'daily', 'warfarin 2', 'day', 'warfarin 3', 'day', 'oxazepam', 'prn', 'anxiety', 'cetirizine', 'oral', 'vitamin', 'tab', 'metamucil', 'psyllium', 'seed sugar gram oral qday', 'ranitidine', 'bid', 'cialis', 'oral', 'terbinafine', 'amiodarone', 'daily', 'aspirin', 'finasteride', 'losartan', 'potassium', 'daily', 'multivitamins', 'tab', 'terbinafine', 'vitamin', 'ciprofloxacin', 'duration', 'days', 'ciprofloxacin', 'mouth', 'disp', 'tablet', 'oxycodone', 'release', 'oxycodone', 'mouth', 'disp', 'tablet', 'amlodipine', 'daily', 'cetirizine', 'oral', 'cialis', 'oral', 'oral daily', 'metamucil', 'psyllium', 'seed sugar gram oral', 'oxazepam', 'prn', 'anxiety', 'ranitidine', 'bid', 'warfarin 3', 'outpatient', 'inr', 'fax office patient pcp', 'atrial fibrillation', 'facility', 'location', 'discharge diagnosis', 'bacterial prostatitis', 'coli bacteremia', 'discharge condition', 'mental status', 'activity', 'ambulatory', 'assistance', 'walker cane discharge', 'hospital low blood pressure bacteria', 'blood icu antibiotics', 'condition', 'bacteria', 'blood', 'infected', 'prostate antibitoics', 'weeks', 'home home', 'doctors', 'medication changes', 'cipro', 'weeks', 'cipro', 'milk', 'iron calcium 2', 'coumadin', 'tylenol', 'mild moderate pain', 'oxycodone', 'prn', 'docusate', 'constipation narcotics', 'followup', 'lf lf', 'location', 'titles', 'titles', 'location', 'numeric identifier', 'appointment', 'thursday', 'department radiology tuesday', 'radiology mri 1', 'sc hospital ward', 'clinical ctr', 'location', 'campus east', 'parking hospital ward', 'garage department', 'surgical specialties', 'location', 'campus east', 'parking hospital ward', 'garage'], ['admission', 'discharge', 'service medicine', 'allergies', 'patient', 'allergies', 'drugs', 'chief complaint', 'surgical invasive procedure', 'stent', 'placement sphincterotomy', 'seconary supratheraputic', 'illness', 'mult pci ischemic cmy', 'lvef', 'afib', 'coumadin', 'mr diet controlled', 'hospital hospital', 'pain', 'cholangitis', 'patient reports', 'intermittent', 'discomfort chest', 'weeks', 'exertion', 'food', 'cramping', 'pain radiation', 'shoulder arms', 'night lying pain', 'angina', 'treated', 'tylenol', 'relief', 'night', 'sleep wife', 'ems ni 4045 hospital hospital', 'chronic', 'increase', 'baseline', 'increase', 'rle swelling chronic', 'edema', 'surgeries', 'diarrhea constipation', 'changes', 'stool', 'urine color', 'swelling left digit', 'weeks', 'bug bite hospital hospital', 'ekg change normal cardiac enzymes', 'bilateral', 'pleural effusions', 'chf', 'exam', 'lasix', 'diuresis', 'labs', 'pmns', 'bands abnl', 'lfts', 'tbili dbili tprot alb lipase', 'elevated', 'chronic acute abd', 'small gallstones', 'gallbladder thickening', 'gb walls', 'biliary dilatation', 'levaquin', 'ctx', 'zofran', 'inr', 'fellow', 'patient', 'ercp', 'medical history', 'mult pci ischemic cardiomyopathy', 'lvef', 'cardiac murmur', 'mr afib', 'diet controlled', 'gout', 'social history', 'home wife', 'location', 'smoked', 'pipes', 'years', 'weeks', 'illicits', 'master craftsman gte', 'retired', 'enjoyment', 'garden', 'work', 'family history', 'noncontributory', 'physical exam', 'afebrile', 'mild hypertension', 'room air', 'pleasant cooperative heent poor dentition', 'sclera conjunctiva', 'nonerythematous neck supple carotid bruit heart regular holosystolic', 'carotids', 'lungs', 'bilaterally abd soft nontender', 'appropriate', 'bowel sounds ext edema rash', 'lesion gait', 'urea', 'anion', 'alk', 'hospital course', 'lastname', 'year', 'male', 'admitted', 'hospital unit', 'septicemia', 'ercp', 'obstructive gallstone stent', 'blood cultures', 'positive', 'pan sensitive coli', 'antibiotics', 'rocephin', 'hospital ampicillin', 'ciprofloxacin', 'appointment', 'outpatient', 'stent', 'removal', 'weeks', 'post discharge', 'ercp', 'ercp', 'abdominal pain', 'diet discharge', 'acute renal failure', 'baseline', 'lasix', 'supportive care sepsis', 'ace inhibitor', 'digoxin', 'cardiomyopathy', 'admission', 'symptoms', 'pancreatitis', 'antiplatelet', 'medications', 'interventions', 'days', 'post', 'beta blocker', 'inital', 'presentation', 'statin', 'hospitalization', 'liver enzymes', 'lipid profile', 'weeks', 'discharge home dose', 'lasix', 'discharge', 'atrial', 'lastname', 'ffp', 'presentation', 'ercp procedure', 'inr', 'simulateous', 'ciprofloxacin', 'supratheraputic', 'discharge instructions', 'rehab facility', 'inr', 'coumadin', 'rate controlled', 'hospitalization digoxin', 'secondary renal insufficiency', 'primary physician', 'hypertension', 'hospitalization', 'lasix', 'metoprolol', 'ace inhibitor', 'discharge', 'week', 'restarting', 'ace instructions', 'rehab facility', 'medications', 'admission', 'discharge medications', 'famotidine', 'tablet', 'tablet', 'metoprolol', 'tartrate', 'tablet', 'tablet', 'bid', 'day', 'senna', 'tablet', 'tablet', 'bid', 'day', 'constipation 4 docusate sodium', 'capsule', 'capsule', 'bid', 'day', 'constipation', 'ciprofloxacin', 'tablet', 'tablet', 'days', 'clopidogrel', 'tablet', 'tablet', 'daily daily', 'simvastatin', 'tablet', 'tablet', 'daily', 'furosemide', 'tablet', 'tablet', 'lisinopril', 'qday', 'discharge disposition', 'care facility', 'location', 'nursing rehabilitation center', 'location', 'discharge diagnosis', 'gallstone pancreatitis', 'stent placement 2 sepsis', 'acute renal failure', 'discharge condition', 'hospitalized gallstone pancreatitis', 'icu acute renal failure', 'rehabilitation facility', 'gain strength', 'medications', 'followup', 'instructions', 'week', 'evaluated', 'outpatient', 'obstructive sleep apnea gastroenterology', 'outpatient clinic', 'appointment', 'ercp', 'bile duct', 'stent', 'removal']]\n"
          ]
        }
      ],
      "source": [
        "# Build a corpus of processed text\n",
        "corpus = []\n",
        "\n",
        "# Iterate through PROCESSED_TEXT on only the first 5 rows\n",
        "for row in range(0, 5):\n",
        "    str_tokens = []\n",
        "    text = ecoli_df['SCISPACY_PROCESSED_TEXT'].iloc[row]\n",
        "    print(f\"Processing row {row}: {text}\")\n",
        "    tokens = scispacy_nlp(text).ents\n",
        "    if not tokens:\n",
        "        print(f\"No entities found in row {row}\")\n",
        "    for i in range(0, len(tokens)):\n",
        "        str_tokens.append(tokens[i].text)\n",
        "    corpus.append(list(str_tokens))\n",
        "\n",
        "print(corpus)\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Word Vectors"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/plain": [
              "array([-0.00283182,  0.0003341 ,  0.00210584, -0.00930757,  0.00493962,\n",
              "        0.00300007, -0.00016927, -0.00295098, -0.00769125,  0.00761941,\n",
              "       -0.00875706, -0.00765256,  0.00448946, -0.00852464, -0.00318288,\n",
              "       -0.00209247, -0.00187576, -0.00707326,  0.00437044,  0.00060505,\n",
              "        0.00375285, -0.00115857,  0.00702125, -0.00964717,  0.00578014,\n",
              "       -0.00506279,  0.0015459 , -0.00702577, -0.00269354, -0.00656069,\n",
              "       -0.003216  ,  0.00979099,  0.00270684,  0.00147945, -0.00622568,\n",
              "        0.00587679, -0.00813168, -0.00256503, -0.00677296, -0.00662668,\n",
              "        0.00226465, -0.00330504,  0.0024074 ,  0.00384249, -0.00610504,\n",
              "       -0.00177989, -0.0029077 , -0.00982303, -0.00974329,  0.00126439,\n",
              "        0.00455817,  0.00010737, -0.00489825,  0.00359114,  0.00146599,\n",
              "       -0.00929965,  0.00726396,  0.00770673, -0.0079496 , -0.00078658,\n",
              "        0.00609485, -0.00271746, -0.00035898, -0.00421122,  0.00579314,\n",
              "        0.00717151,  0.00208446, -0.00464852, -0.0021714 , -0.00382152,\n",
              "       -0.00986911,  0.00796451, -0.00031879, -0.00081772,  0.00724496,\n",
              "       -0.00890595,  0.00634484, -0.00772018, -0.00543171,  0.00521962,\n",
              "       -0.00361561, -0.00347255, -0.00659452, -0.00371564, -0.00254816,\n",
              "       -0.00414889,  0.00945963,  0.00969367, -0.00015466, -0.00021801,\n",
              "       -0.00550449,  0.00813548, -0.00495822,  0.00585738,  0.0095048 ,\n",
              "        0.00592194, -0.00077559,  0.00526558,  0.00714827, -0.00407944],\n",
              "      dtype=float32)"
            ]
          },
          "execution_count": 78,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "from gensim.models import Word2Vec\n",
        "word2vec_model = Word2Vec(corpus, min_count=1)\n",
        "# Find the word vector for 'antibiotics'\n",
        "word2vec_model.wv['antibiotics']"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "6uZGlBeBzXGt",
        "outputId": "eec00e69-d6a3-419a-968d-0ae7bb9344b8"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "[('discharge', 0.2776538133621216),\n",
              " ('reflexes bilaterally physical exam transfer', 0.27713921666145325),\n",
              " ('lungs ctab', 0.2666809558868408),\n",
              " ('dose', 0.26522624492645264),\n",
              " ('surgeries', 0.2628735899925232),\n",
              " ('metronidazole', 0.25460758805274963),\n",
              " ('trend lfts', 0.24225164949893951),\n",
              " ('autopsy', 0.24105584621429443),\n",
              " ('gram positive cocci bacteremia', 0.2357354760169983),\n",
              " ('daily', 0.23296909034252167)]"
            ]
          },
          "execution_count": 32,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "word2vec_model.wv.similar_by_word('antibiotics') "
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/plain": [
              "-0.011203538"
            ]
          },
          "execution_count": 43,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "\n",
        "word2vec_model.wv.similarity('antibiotics', 'bacteria')\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# t-SNE Visualization"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "vgxqcOA10mFu",
        "outputId": "64db3721-38ca-4e63-923e-838218960e25"
      },
      "outputs": [],
      "source": [
        "from sklearn.cluster import KMeans\n",
        "import random\n",
        "\n",
        "def tsne_plot(model, words, preTrained=False, max_words=100, n_clusters=5):\n",
        "    \"Creates and TSNE model and plots it with K-Means clustering\"\n",
        "    labels = []\n",
        "    tokens = []\n",
        "\n",
        "    # Sample a subset of words if there are too many\n",
        "    if len(words) > max_words:\n",
        "        words = random.sample(words, max_words)\n",
        "\n",
        "    for word in words:\n",
        "        if preTrained:\n",
        "            tokens.append(model[word])\n",
        "        else:\n",
        "            tokens.append(model.wv[word])\n",
        "        labels.append(word)\n",
        "\n",
        "    tokens = np.array(tokens)\n",
        "    tsne_model = TSNE(perplexity=5, early_exaggeration=50, n_components=2, init='pca', n_iter=1000, random_state=23)\n",
        "    new_values = tsne_model.fit_transform(tokens)\n",
        "\n",
        "    # Perform K-Means clustering\n",
        "    kmeans = KMeans(n_clusters=n_clusters, random_state=23)\n",
        "    kmeans.fit(new_values)\n",
        "    cluster_labels = kmeans.labels_\n",
        "\n",
        "    x = []\n",
        "    y = []\n",
        "    for value in new_values:\n",
        "        x.append(value[0])\n",
        "        y.append(value[1])\n",
        "\n",
        "    plt.figure(figsize=(16, 16))\n",
        "    colors = plt.cm.rainbow(np.linspace(0, 1, n_clusters))\n",
        "    for i in range(len(x)):\n",
        "        plt.scatter(x[i], y[i], color=colors[cluster_labels[i]])\n",
        "        plt.annotate(labels[i],\n",
        "                     xy=(x[i], y[i]),\n",
        "                     xytext=(5, 2),\n",
        "                     textcoords='offset points',\n",
        "                     ha='right',\n",
        "                     va='bottom')\n",
        "    plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Mptde60O3ttL",
        "outputId": "67faa59e-99fa-42a1-dcbd-b7f52bac4b4c"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/Users/jefdewitt/miniconda3/envs/new_env/lib/python3.10/site-packages/sklearn/manifold/_t_sne.py:1164: FutureWarning: 'n_iter' was renamed to 'max_iter' in version 1.5 and will be removed in 1.7.\n",
            "  warnings.warn(\n"
          ]
        },
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 1600x1600 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "# Visualize word embeddings using TSNE, indexed by the word2vec model's vocabulary\n",
        "vocabs = word2vec_model.wv.index_to_key\n",
        "new_v = list(vocabs)\n",
        "tsne_plot(word2vec_model, new_v, preTrained=False, max_words=150)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "4m2uIRP9irp_"
      },
      "source": [
        "# Topic Modeling w/ LDA"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "VPR2wbc7g8uq",
        "outputId": "00a3799a-9a80-455e-cf78-4c5292fe33b9"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Topic 0: mg, po, tablet, patient, sig\n",
            "\n",
            "\n",
            "Topic 1: blood, mg, tablet, po, patient\n",
            "\n",
            "\n",
            "Topic 2: blood, patient, mg, po, discharge\n",
            "\n",
            "\n",
            "Topic 3: mg, tablet, blood, patient, sig\n",
            "\n",
            "\n",
            "Topic 4: mg, po, patient, daily, blood\n",
            "\n",
            "\n",
            "LDA visualization saved to /Users/jefdewitt/Documents/education/UT-Austin/courses/ai-in-healthcare/module-6/lda_visualization.html\n"
          ]
        }
      ],
      "source": [
        "import pyLDAvis\n",
        "import pyLDAvis.gensim_models\n",
        "from gensim import corpora\n",
        "from gensim.models import LdaModel\n",
        "from sklearn.feature_extraction.text import CountVectorizer\n",
        "import re\n",
        "\n",
        "def preprocess_texts(texts):\n",
        "    # Remove numbers from the texts\n",
        "    texts = [re.sub(r'\\d+', '', text) for text in texts]\n",
        "    \n",
        "    # Tokenize and clean the texts\n",
        "    vectorizer = CountVectorizer(stop_words='english')\n",
        "    text_matrix = vectorizer.fit_transform(texts)\n",
        "    tokens = [text.split() for text in texts]\n",
        "    return tokens, vectorizer\n",
        "\n",
        "def get_top_words(lda_model, num_words=5):\n",
        "    top_words = {}\n",
        "    for idx, topic in lda_model.print_topics(-1):\n",
        "        words = topic.split(' + ')\n",
        "        top_words[idx] = ', '.join([word.split('*')[1].strip('\"') for word in words[:num_words]])\n",
        "    return top_words\n",
        "\n",
        "def lda_topic_modeling(texts, n_topics=5):\n",
        "    tokens, vectorizer = preprocess_texts(texts)\n",
        "    \n",
        "    # Create a dictionary and corpus for LDA\n",
        "    dictionary = corpora.Dictionary(tokens)\n",
        "    corpus = [dictionary.doc2bow(token) for token in tokens]\n",
        "\n",
        "    # Fit the LDA model\n",
        "    lda_model = LdaModel(corpus, num_topics=n_topics, id2word=dictionary, random_state=23)\n",
        "\n",
        "    # Print the top words for each topic\n",
        "    top_words = get_top_words(lda_model)\n",
        "    for idx, words in top_words.items():\n",
        "        print(f\"Topic {idx}: {words}\")\n",
        "        print(\"\\n\")\n",
        "\n",
        "    # Visualize the topics\n",
        "    pyLDAvis.enable_notebook()\n",
        "    panel = pyLDAvis.gensim_models.prepare(lda_model, corpus, dictionary)\n",
        "    return panel\n",
        "\n",
        "texts = ecoli_df['SCISPACY_PROCESSED_TEXT'].tolist()\n",
        "panel = lda_topic_modeling(texts, n_topics=5)\n",
        "\n",
        "# Save the visualization to an HTML file\n",
        "output_filepath = '/Users/jefdewitt/Documents/education/UT-Austin/courses/ai-in-healthcare/module-6/lda_visualization.html'\n",
        "pyLDAvis.save_html(panel, output_filepath)\n",
        "print(f\"LDA visualization saved to {output_filepath}\")"
      ]
    }
  ],
  "metadata": {
    "accelerator": "TPU",
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "display_name": "new_env",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.10.16"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}
